2023 Annual Meeting | P14 - Poster Session 14

Date Thursday 04/27/23

Time 11:45 AM - 12:45 PM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Neuro-oncology, Aging, Dementia, and Behavioral Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, ��ɫ��, Research, and Methodology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Headache, Infectious Disease, Movement Disorders, Multiple Sclerosis, Neuro Trauma and Critical Care, Neuromuscular and Clinical Neurophysiology (EMG)

CME Available 0.00 CME credit

Event Timeline
11:45 AM - 12:45 PM EST	Abstract	9-001 - Treatment Outcomes During Brivaracetam Treatment by Seizure Freedom Status at Baseline: Post hoc Analysis of a Real-world, US Study Prashant Dongre, MD, MBBS
11:45 AM - 12:45 PM EST	Abstract	9-002 - Cognitive debrief of the Clinical Global Impression of Improvement for Nonseizure Symptoms measure in Dravet syndrome (DS) and Lennox–Gastaut syndrome (LGS): The Caregiver Perspective Drishti Shah, PhD
11:45 AM - 12:45 PM EST	Abstract	9-003 - Efficacy, Safety, and Tolerability of Adjunctive Eslicarbazepine Acetate in Focal Seizure Patients With Focal to Bilateral Tonic-Clonic Seizures at Baseline Steve Chung, MD, FAAN
11:45 AM - 12:45 PM EST	Abstract	9-004 - Long-term Safety and Efficacy of Add-on Cannabidiol (CBD) for Seizures Associated With Tuberous Sclerosis Complex (TSC): 3-Year Results From GWPCARE6 Open-Label Extension (OLE) Jessica DuHaime, PharmD
11:45 AM - 12:45 PM EST	Abstract	9-005 - Predictors of Sustainability of Response With Cenobamate: Post-hoc Subset Analysis of a Phase 3, Open-Label, Study Sean Stern
11:45 AM - 12:45 PM EST	Abstract	9-006 - Seizure Outcomes With Cannabidiol (CBD) in Pediatric Versus Adult Patients With Lennox-Gastaut Syndrome (LGS) and Dravet Syndrome (DS): Subgroup Analysis of BECOME, a Caregiver Survey Timothy B. Saurer, PhD
11:45 AM - 12:45 PM EST	Abstract	9-007 - Cognitive and Behavioral Effects of Adjunctive Brivaracetam in Children and Adolescents with Focal Seizures: Final Data From an Open-label Follow-up Trial Frank Tennigkeit, PhD
11:45 AM - 12:45 PM EST	Abstract	9-008 - Nonseizure Outcomes With Cannabidiol (CBD) in Pediatric Versus Adult Patients With Lennox-Gastaut Syndrome (LGS) and Dravet Syndrome (DS): Subgroup Analysis of BECOME, a Caregiver Survey Catherine L. Passariello, PhD
11:45 AM - 12:45 PM EST	Abstract	9-009 - Assessing Biases in the Diagnosis of Psychogenic Non-Epileptic Spells (PNES) Ramsha A. Bhutta, MD
11:45 AM - 12:45 PM EST	Abstract	9-010 - Pregnancy and Breastfeeding: A Survey of People with Epilepsy about their Experiences and Attitudes Denise Li, MD
11:45 AM - 12:45 PM EST	Abstract	9-011 - Seizure Control in Women with Epilepsy Undergoing Assisted Reproductive Technology Aisha Abdulrazaq, MBBS
11:45 AM - 12:45 PM EST	Abstract	15-001 - SAFE-TE: Staff Awareness and Familiarity with Epilepsy through Technology and ��ɫ�� Johnny Chen, Other
11:45 AM - 12:45 PM EST	Abstract	15-003 - Online CME-Certified Expert Panel Discussion Improves Awareness Among Neurologists Regarding Seizure Freedom in Patients with Epilepsy Thomas Finnegan, Jr., PhD
11:45 AM - 12:45 PM EST	Abstract	15-004 - Creating a Sustainable Model for Epilepsy Transition with Objective Outcome Measurements Elizabeth B. Edwards
11:45 AM - 12:45 PM EST	Abstract	15-005 - A New Era in the Management of Rett Syndrome: Are Neurologists Ready for a Changing Management Landscape? Carole Drexel
11:45 AM - 12:45 PM EST	Abstract	3-001 - Patient Characteristics and Persistence Among Commercially Insured Patients With Multiple Sclerosis Initiating Cladribine Tablets Chris M. Kozma
11:45 AM - 12:45 PM EST	Abstract	3-002 - Unilateral ‘Ophthalmic nerve pattern’ of sensory loss from a demyelinating lesion in lateral cervical cord: a lesson in neuroanatomy Mirza Omari, MD
11:45 AM - 12:45 PM EST	Abstract	3-004 - Delayed Onset Cryptogenic Organizing Pneumonia in Alemtuzumab Treatment Patient Yao Cheng, MBBS
11:45 AM - 12:45 PM EST	Abstract	3-005 - Tolosa Hunt Syndrome, A Variant of Neuroinflammation: A Case Report Jonathon Chon Teng Chio, PhD
11:45 AM - 12:45 PM EST	Abstract	3-007 - Balo’s Concentric Sclerosis presenting as Sensorineural Hearing Loss Anvita Potluri, MD
11:45 AM - 12:45 PM EST	Abstract	3-008 - Real-world effectiveness of switching treatment after initial platform injectable disease-modifying therapies in pediatric multiple sclerosis in the US Aaron W. Abrams, MD
11:45 AM - 12:45 PM EST	Abstract	3-009 - Cost, efficacy and safety comparison between early intensive and escalating strategies for multiple sclerosis: a Systematic Review and Meta-analysis Leonardo Pipek, MD
11:45 AM - 12:45 PM EST	Abstract	3-010 - Extended Interval Dosing of Ocrelizumab in Patients with Multiple Sclerosis Is Not Associated with Meaningful Differences in Disease Activity Nicole Bou Rjeily, MD
11:45 AM - 12:45 PM EST	Abstract	3-011 - Natalizumab Extended Interval Dosing (EID) is Associated with a Reduced Risk of Progressive Multifocal Leukoencephalopathy (PML) Compared with Every-4-Week (Q4W) Dosing: Updated Analysis of the TOUCH® Prescribing Program Database Lana Zhovtis Ryerson, MD, FAAN
11:45 AM - 12:45 PM EST	Abstract	3-012 - A Real-life study of Alemtuzumab in patients with Multiple Sclerosis: Kuwait’s Experience Raed Alroughani, MD, FAAN
11:45 AM - 12:45 PM EST	Abstract	3-013 - Approach to Balancing Risk in Multiple Sclerosis Management: a Worldwide Practice Survey Jodie Roberts, MD, MSc, FRCPC
11:45 AM - 12:45 PM EST	Abstract	3-015 - Autologous hematopoietic stem cell transplantation in multiple sclerosis: A 20-year single center's experience in Mexico. Mario E. Rodriguez Estrada, MD
11:45 AM - 12:45 PM EST	Abstract	3-016 - The Role of C3 and C4 Complement Levels in the Differential Diagnosis of Central Nervous System Demyelinating Diseases Asli Tuncer
11:45 AM - 12:45 PM EST	Abstract	3-017 - Ixekizumab-associated transverse myelopathy in a patient with psoriatic arthritis Mattia Rosso, MD
11:45 AM - 12:45 PM EST	Abstract	3-018 - Remote Monitoring of Neurological Patients Marc Fischer
11:45 AM - 12:45 PM EST	Abstract	12-001 - GFAP astrocytopathy presenting after COVID-19 infection with meningoencephalomyelitis and good recovery with immunotherapy Kun-Wei Song, MD
11:45 AM - 12:45 PM EST	Abstract	12-002 - Association between Diabetic Control (HbA1C) and the Risk of Developing Neurological Post-Acute Sequelae of COVID-19 (PASC) Anam K. Shaikh
11:45 AM - 12:45 PM EST	Abstract	12-003 - Fatigue, Somnolence and Depression Persist After Six Month In Recovered Individual After The Acute Covid-19 Rafael Joao
11:45 AM - 12:45 PM EST	Abstract	12-004 - Fulminant Idiopathic Intracranial Hypertension Refractory to Treatment Associated to SARS-CoV-2: A Case Report Ricardo Murguia Fuentes, MD
11:45 AM - 12:45 PM EST	Abstract	12-005 - Long Covid Infection and Peripheral Neuropathy – Initial Presentation of Eosinophilic Granulomatous Polyangiitis (EGPA) Kereisha Donegal, MD
11:45 AM - 12:45 PM EST	Abstract	12-006 - Vaccine-induced immune thrombotic thrombocytopenia: an emerging disease during the COVID-19 pandemic Naiade Couto, MD
11:45 AM - 12:45 PM EST	Abstract	12-007 - Mild Encephalopathy with Reversible Splenium Lesion Associated with SARS-CoV-2 Infection Atef Kokash, DO
11:45 AM - 12:45 PM EST	Abstract	6-001 - A Nationwide Analysis of Ischemic Stroke Outcomes in Patients with COVID-19 Aayushi Garg, MBBS
11:45 AM - 12:45 PM EST	Abstract	6-002 - Stroke Metrics During Covid-19: a Comprehensive Stroke Center Experience Lara Carvalho de Oliveira
11:45 AM - 12:45 PM EST	Abstract	6-003 - Compare complications during hospitalization between patients with and without dysphagia following acute stroke. Sandra Badial
11:45 AM - 12:45 PM EST	Abstract	6-004 - Outcomes of Multiple Sclerosis Patients following Admission for Acute Ischemic Stroke in the United States Sailaja Sanikommu, MBBS
11:45 AM - 12:45 PM EST	Abstract	6-006 - Long Term Follow Up of Patients with Stroke after SARS-CoV-2 infection and Incidence of Neurological Post-Acute Sequelae of COVID-19 Anam K. Shaikh
11:45 AM - 12:45 PM EST	Abstract	6-007 - Does Elevated Inflammatory Markers Predict Functional Outcomes in Hospitalized Patients with COVID-19 and Acute stroke? Omar Elsekaily, MBBS
11:45 AM - 12:45 PM EST	Abstract	6-008 - Feasibility of the mobile app Destroke for clinical stroke monitoring based on the NIH Stroke Scale Evan Noch, MD
11:45 AM - 12:45 PM EST	Abstract	6-009 - Stroke Patient Characteristics Associated with 30-day Hospital Readmissions: A Retrospective, Intra-hospital network Study Kevin Spiegler, MD, PhD
11:45 AM - 12:45 PM EST	Abstract	6-010 - Rapid Development of High-Grade Dural Arteriovenous Fistula During Pregnancy: A Case Report Nazanin Sheibani, MD
11:45 AM - 12:45 PM EST	Abstract	6-012 - No Association Between Outcomes And Anti-Factor Xa Levels For Heparin Monitoring In Patients With Cerebral Venous Thrombosis Yasaman Pirahanchi, MD
11:45 AM - 12:45 PM EST	Abstract	6-013 - Risk Factors and Outcome of Cerebrovascular Complications in Transplant Recipients Angel J. Cadena Tejada, MD
11:45 AM - 12:45 PM EST	Abstract	6-014 - A Novel Mechanism of the “Three Territory Sign” in Acute Ischemic Stroke Michael A. Figueroa, DO
11:45 AM - 12:45 PM EST	Abstract	6-015 - Disorders of Consciousness and Delays in Ischemic Stroke Treatment Benjamin M. Jadow, MD
11:45 AM - 12:45 PM EST	Abstract	6-016 - A Retrospective Analysis of Co-morbidities in Stroke Patients with COVID Mohammad A. Sheikh, MBBS
11:45 AM - 12:45 PM EST	Abstract	6-017 - Association of Blood Pressure Parameters in Unsecured Aneurysmal Subarachnoid Hemorrhage and Outcomes Ariyaporn Haripottawekul
11:45 AM - 12:45 PM EST	Abstract	6-019 - Blunt Traumatic Cerebrovascular Injury and Stroke: The Need for a High Index of Suspicion when Initial Vascular Imaging is Negative - A Single Center Case Series. Ahmer Asif, MD
11:45 AM - 12:45 PM EST	Abstract	6-020 - Study of Risk Factors and Outcome Evaluation in Patients with Stroke with Intracranial versus Extracranial Atherosclerotic Arterial Disease Aashka Ponda, Other
11:45 AM - 12:45 PM EST	Abstract	6-022 - Iron Deficiency Anemia and Ischemic Stroke in Premenopausal Women Hanah A. Imam, MBBS
11:45 AM - 12:45 PM EST	Abstract	6-023 - Acute Neurological Consultation in Patients with Cervical Orthopedic Intervention Ashwini Gadalay, MBBS
11:45 AM - 12:45 PM EST	Abstract	6-024 - Age-related Macular Degeneration, Incident Ischemic Stroke, and Cognitive impairment Bhrugun Anisetti, MBBS
11:45 AM - 12:45 PM EST	Abstract	6-025 - Relationships among Hospital Acute Ischemic Stroke Volumes, Hospital Characteristics, and Outcomes in the US Louise M. McCarthy, MB BCh BAO
11:45 AM - 12:45 PM EST	Abstract	6-026 - Prevalence of Neurogenic Stress Cardiomyopathy in Acute Ischemic Stroke and Relationship with Leukocytosis Laura Naydovich, MD
11:45 AM - 12:45 PM EST	Abstract	6-027 - Clinical, Anatomical, and Demographic features associated with the use of Patient-Specific Advanced Visualization Modeling in Cerebrovascular Disease Vishal N. Bhimarasetty, MSc
11:45 AM - 12:45 PM EST	Abstract	6-028 - Patients with COVID-19 Infection and Stroke have Higher than Expected Mortality, Regardless of the Primary Presentation Jintong Liu
11:45 AM - 12:45 PM EST	Abstract	6-029 - Outcome of Lacunar vs Non-lacunar Infarcts in a Prospective Stroke Database Prabandh R. Buchhanolla, MBBS
11:45 AM - 12:45 PM EST	Abstract	6-030 - Unvaccinated: An unrecognized risk factor for stroke Divya Gupta, MD
11:45 AM - 12:45 PM EST	Abstract	6-031 - Systemic inflammatory response syndrome deteriorates the outcomes of mechanical thrombectomy in acute stroke Mostafa Jafari, MD
11:45 AM - 12:45 PM EST	Abstract	6-032 - Metabolic Syndrome as a Risk Factor in Latin American Patients with Intracerebral Hemorrhage Enrique Gomez Figueroa, MD, MSc
11:45 AM - 12:45 PM EST	Abstract	7-001 - Association of Life’s Simple 7 with Brain Imaging Outcomes Among Hispanics/Latinos. Results from the Study of Latinos-Investigation of Neurocognitive Aging-MRI (SOL-INCA-MRI) Ancillary Study Fernando D. Testai, MD, PhD, FAAN
11:45 AM - 12:45 PM EST	Abstract	7-002 - Ethnic Disparities in Clinical Presentation of Patients with Early-Onset Alzheimer’s Disease Meredith F. Yang
11:45 AM - 12:45 PM EST	Abstract	7-003 - Examining Age-Specific Barriers and Facilitators to Research Participation in Underrepresented Americans Gregory S. Day, MD, MSc, FAAN
11:45 AM - 12:45 PM EST	Abstract	7-004 - The Cost Burden of Alzheimer’s Disease on Care Partners Luis Rafael Solís-Tarazona, MD
11:45 AM - 12:45 PM EST	Abstract	7-005 - Online CME-certified Survey Identifies Sources for Clinical Practice Gaps Among Neurologists and PCPs Regarding the Early Recognition of Alzheimer’s Disease
11:45 AM - 12:45 PM EST	Abstract	7-006 - Financial Toxicity in Dementia Caregiving Danielle M. Hart
11:45 AM - 12:45 PM EST	Abstract	7-007 - The Impact of Social History on the Development of Alzheimer’s Disease Madisen L. Faulkner
11:45 AM - 12:45 PM EST	Abstract	7-009 - Cognitive Health in Underrepresented Populations—Early Learnings From INTUITION: A Brain Health Study Matt Hobbs
11:45 AM - 12:45 PM EST	Abstract	7-010 - The Impact of Alzheimer’s Disease on Care Partners Luis Rafael Solís-Tarazona, MD
11:45 AM - 12:45 PM EST	Abstract	1-001 - Evaluating the Performance of the IMPACT Model in the Prehospital TXA for TBI Trial H. E. Hinson, MD, MCR, FAAN
11:45 AM - 12:45 PM EST	Abstract	1-002 - Relationship Between White Matter Hyperintensities and Blood Biomarkers of Axonal Injury and White Matter Integrity Abbie Chan
11:45 AM - 12:45 PM EST	Abstract	1-003 - Relationship Between Time of Hospital Arrival and Clinical and Fluid Biomarker Outcomes in Traumatic Brain Injury Aaron Anandarajah
11:45 AM - 12:45 PM EST	Abstract	1-004 - Interventions to Optimize Spinal Cord Perfusion in Patients with Acute Traumatic Spinal Cord Injury: An Updated Systematic Review David E. Kahn, MD
11:45 AM - 12:45 PM EST	Abstract	1-005 - Resting State fMRI for Neuroprognostication in Traumatic Brain Injury: Clinical Experience of Evaluation for Covert Consciousness and Epileptogenic Networks in Acute Coma Nikoloz Karazanashvili, MD
11:45 AM - 12:45 PM EST	Abstract	1-006 - Delayed Posttraumatic Intracranial Hemorrhage in a Patient not on Antithrombotic Therapy Victoria Q. Tay
11:45 AM - 12:45 PM EST	Abstract	10-001 - Early Post Radiation Neuropathy: Complex Pathogenesis Including Microvasculitis and Tumor Spread Michael P. Skolka, MD
11:45 AM - 12:45 PM EST	Abstract	10-002 - Title: Exploring Relationships Between Ultrasound-Measured Pre-Operative Median Nerve Echointensity and Successful Carpal Tunnel Release -A Retrospective Review Yohei Harada, MD
11:45 AM - 12:45 PM EST	Abstract	10-003 - Morphological Changes on Neuromuscular Ultrasound in Nerves Distal to Gunshot Injuries Patrick Fagan, MD
11:45 AM - 12:45 PM EST	Abstract	10-004 - Serum Neurofilament Light Chain Levels in Small Fiber Neuropathy Patients with Skin Denervation and Ongoing Neuropathic Symptoms Daniela N. Zohar, MD
11:45 AM - 12:45 PM EST	Abstract	10-005 - Recognizing Neuropathic Pain as a Symptom of Charcot-Marie-Tooth Disease that impacts Quality of Life Catherine W. Imossi, MD
11:45 AM - 12:45 PM EST	Abstract	10-006 - A Phase 2/3 Placebo-Controlled, Parallel Group, Randomized Withdrawal Study to Evaluate the Efficacy and Safety of Nipocalimab for Adults with Chronic Inflammatory Demyelinating Polyneuropathy: the ARISE study Lisa M. Ford, MD, FAAN
11:45 AM - 12:45 PM EST	Abstract	10-007 - Small Vessel Vasculitis in Small Fiber Neuropathy with TS-HDS, FGFR-3, or Plexin D1 antibodies Lawrence A. Zeidman, MD, FAAN
11:45 AM - 12:45 PM EST	Abstract	10-008 - Anti-Plexin D1 Antibodies in Axonal Polyneuropathy Isheeta S. Govardhan
11:45 AM - 12:45 PM EST	Abstract	10-009 - Description of a Rare Compound Heterozygous Transthyretin Mutation Val30Met/Val122Ile Conferring Early Onset Hereditary Amyloidosis with Severe Features Joshua Nardin, DO
11:45 AM - 12:45 PM EST	Abstract	10-010 - Characterization of Polyneuropathy in Patients Receiving Enfortumab Vedotin for the Treatment of Metastatic Urothelial Carcinoma Melody Badii, MD
11:45 AM - 12:45 PM EST	Abstract	10-011 - Clinical Characteristics, Treatment and Outcomes of Patients with Paraneoplastic Neuropathies. A Retrospective Single-Center Study in Argentina. Francisco Caiza Zambrano, MD
11:45 AM - 12:45 PM EST	Abstract	10-012 - Presentations of Peripheral Neuropathy with Anti-Fibroblast Growth Factor Receptor-3 Antibodies Clover Youn, MD
11:45 AM - 12:45 PM EST	Abstract	10-013 - Surgical Release of Ulnar and Median Nerves in CMT1A: Prevention and Treatment of a Second Hit Will McKeen, MD
11:45 AM - 12:45 PM EST	Abstract	10-014 - A Case of Charcot-Marrie-Tooth 1F Mimicking Chronic Inflammatory Demyelinating Polyradiculopathy Nasrin Rahimian, MD
11:45 AM - 12:45 PM EST	Abstract	10-015 - Evidence of Lumbosacral Plexus Involvement on MR Neurography in Early Guillain-Barré Syndrome Ashley Weng, MD
11:45 AM - 12:45 PM EST	Abstract	4-001 - Falsely Reassuring Head CT Delays Diagnosis in Childhood Arterial Ischemic Stroke Vivian Chiang, MD
11:45 AM - 12:45 PM EST	Abstract	4-003 - Migraine Disability Evaluation in Indian Children by Pediatric Migraine Disability Assessment (PedMIDAS) Scale: A Prospective Observational Study Lokesh Saini, DM
11:45 AM - 12:45 PM EST	Abstract	4-004 - Cow’s Milk Anemia In Childhood Manifesting As Severe Cerebral Venous Sinus Thrombosis Catherine M. Amlie-Lefond, MD, FAAN
11:45 AM - 12:45 PM EST	Abstract	4-005 - Utility of Neuroimaging in Children Presenting to the Emergency Department with Altered Mental Status Giovanni Castellucci, MD, MS
11:45 AM - 12:45 PM EST	Abstract	4-006 - Peripheral Neuropathy in a Pediatric ALL Patient Douglas A. Wells, Jr., MD
11:45 AM - 12:45 PM EST	Abstract	4-007 - Neurocognitive Manifestations of Individuals with NF1 Microdeletions Jenny P. Garzon, MD
11:45 AM - 12:45 PM EST	Abstract	4-008 - Development and internal validation of a clinical risk score to predict incident renal and pulmonary tumors in people with tuberous sclerosis complex Frédéric Loubert
11:45 AM - 12:45 PM EST	Abstract	4-009 - Outcomes in Children with Shaken Baby Syndrome and Seizures Katelyn Stebbins
11:45 AM - 12:45 PM EST	Abstract	4-010 - Metabolic Stroke as a Clinical Manifestation of Zhu-Tokita-Takenouchi-Kim (ZTTK) Syndrome: A Case Series Jorge L. Morales, MD
11:45 AM - 12:45 PM EST	Abstract	4-012 - Trends in Early MRI Utilization in Critically Ill Children with Severe TBI: a Single Center Experience, 2010-2021 Anna Janas, MD, PhD
11:45 AM - 12:45 PM EST	Abstract	13-002 - Under Pressure: Neurocysticercosis Manifests Itself as Intracranial Hypertension Erin Britt, MD
11:45 AM - 12:45 PM EST	Abstract	13-004 - Neurotoxoplasmosis: a 5-year story in the Dominican Republic María Cedeño-Bruzual, MD
11:45 AM - 12:45 PM EST	Abstract	13-005 - Post-malaria neurological syndrome - chronic ailments of the acute parasitic infection. Maria Andreina Hernandez, MD
11:45 AM - 12:45 PM EST	Abstract	5-001 - Acetyl-L-Leucine for Niemann-Pick type C: A Multinational Double-blind Randomized Placebo-controlled Crossover Study Tatiana T. Bremova-Ertl, MD, PhD
11:45 AM - 12:45 PM EST	Abstract	5-002 - Lamotrigine as a First-line Agent in the Management of Paroxysmal Kinesigenic Dyskinesia Heather Leduc-Pessah, MD, PhD
11:45 AM - 12:45 PM EST	Abstract	5-003 - Vertical supranuclear gaze palsy in Primary Familial Brain Calcification associated with a novel SLC20A2 mutation Nikolai Gil D. Reyes, MD
11:45 AM - 12:45 PM EST	Abstract	5-004 - Frequency, Classification, and Timing of Movement Disorders in Rapidly Progressive Dementia Pierpaolo Turcano, MD
11:45 AM - 12:45 PM EST	Abstract	5-005 - A familial case of Congenital Mirror Movement (CMM) Syndrome Associated With A Novel DCC Variant Ankur Nayyar, MD
11:45 AM - 12:45 PM EST	Abstract	5-006 - Identification of novel compound heterozygous mutation in Niemann-Pick disease type C gene Ali H. Abusrair, MD
11:45 AM - 12:45 PM EST	Abstract	5-007 - A Cross-Sectional Evaluation of Health Resource Use in Patients with Functional Neurological Disorders Referred to a Tertiary Neuroscience Centre Brian W. O'Mahony, MD
11:45 AM - 12:45 PM EST	Abstract	5-008 - Pain Reduction in Adult Patients with Limb Spasticity Following a Single IncobotulinumtoxinA Injection: an Analysis of Pooled Data from Phase 2 and 3 Studies Jorg Wissel
11:45 AM - 12:45 PM EST	Abstract	5-009 - The Economic Cost of Functional Neurological Disorders: A Systematic Review Brian W. O'Mahony, MD
11:45 AM - 12:45 PM EST	Abstract	5-013 - Safety of opicapone after 5 years of post-marketing experience worldwide Luis Guedes, MD
11:45 AM - 12:45 PM EST	Abstract	5-014 - Consistent Effects of Once-Daily Opicapone 50 mg on COMT Activity Across Participants: A Pooled Post Hoc Analysis of Two Phase 1 Studies Eric Jen
11:45 AM - 12:45 PM EST	Abstract	5-015 - Perspectives on Parkinson's Disease Medications: A Qualitative Study of People with Parkinson's Disease Steve Arcona, PhD
11:45 AM - 12:45 PM EST	Abstract	5-016 - A novel retromer stabilizer as a potential treatment for Parkinson’s disease Michele Persico, MD
11:45 AM - 12:45 PM EST	Abstract	2-001 - Suicide in Veterans with Post-Traumatic Headache: An Analysis of Health Systems Data Sarah Anthony, Other
11:45 AM - 12:45 PM EST	Abstract	2-002 - The relationship between gender, peer victimization, mental health, and frequent headaches in adolescents: A Canadian population-based observational study Christelle Nilles, MD
11:45 AM - 12:45 PM EST	Abstract	2-003 - Clinical characteristics and factors associated with headaches following COVID-19 vaccination: a cross-sectional cohort study Saba Ilkhani, MD
11:45 AM - 12:45 PM EST	Abstract	2-004 - Migraine Prevalence in Gender Identity Minorities David C. Wegener, Jr., MD
11:45 AM - 12:45 PM EST	Abstract	2-005 - Twenty years of population-based studies in US adults with migraine reveal minimal improvement in care Julia L. Jones, PhD
11:45 AM - 12:45 PM EST	Abstract	2-006 - Different Experiences in Chronic Migraine Etiology, Treatment and Comorbidities of Hawaii’s Ethnic Groups Enrique Carrazana
11:45 AM - 12:45 PM EST	Abstract	2-007 - Health concerns and treatment perspectives among US adults with current versus previous high-frequency headache/migraine and acute medication overuse: The Harris Poll Migraine Report Card Survey Amaal J. Starling, MD, FAAN
11:45 AM - 12:45 PM EST	Abstract	2-008 - Treatment Effects of Celecoxib Oral Solution in Migraine With Aura and Without Aura: Post-Hoc Analysis of Results From Two Randomized, Double-Blind Placebo-Controlled Trials Stewart J. Tepper, MD
11:45 AM - 12:45 PM EST	Abstract	2-009 - Efficacy of Celecoxib Oral Solution in Adults With and Without Baseline Nausea: Post Hoc Analysis of Results From Two Randomized, Double-Blind Placebo-Controlled Trials in the Acute Treatment of Migraine Stewart J. Tepper, MD
11:45 AM - 12:45 PM EST	Abstract	2-010 - Transnasal Evaporative Cooling Device for Migraine: A Randomized Trial Larry "LC" Charleston IV, MD, MSc, FAHS, FANA, FAAN
11:45 AM - 12:45 PM EST	Abstract	2-011 - Safety of Concomitant Triptan and INP104 Use From the Phase 3 STOP 301 Study in Migraine Patients Sheena K. Aurora, MD
11:45 AM - 12:45 PM EST	Abstract	2-012 - Assessing the Synergistic effect of Vitamin supplementation and Migraine preventative management in children and adolescents with chronic migraine- retrospective cohort analysis Peyton I. Crest
11:45 AM - 12:45 PM EST	Abstract	11-001 - MALT Lymphoma Presenting as Symptomatic Optic Neuritis: A Case Report Dan Tong Jia, MD
11:45 AM - 12:45 PM EST	Abstract	11-002 - All that enhances is not cancer: Cerebral amyloid angiopathy mimicking leptomeningeal enhancement in the two patients with advanced cancer Sadia Waheed, MBBS
11:45 AM - 12:45 PM EST	Abstract	11-003 - A Case of CNS Lymphoma Imitating Post-Vaccination ADEM Samuel Frank, MD
11:45 AM - 12:45 PM EST	Abstract	11-004 - CNS Aspergillosis Following BTK Inhibitors Mimicking Secondary CNS Lymphoma – A Case Series Naina Murthy
11:45 AM - 12:45 PM EST	Abstract	11-005 - Stroke Like Presentation Of CNS Lymphoma Deema Sawass Najjar, MD
11:45 AM - 12:45 PM EST	Abstract	11-006 - A Case Report of Primary Central Nervous System T-Cell Lymphoma Mimicking Autoimmune Encephalitis Kristi M. Anderson, DO

Faculty Disclosures
Evan Noch, MD	Dr. Noch has received personal compensation for serving as an employee of Destroke, Inc.. Dr. Noch has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lexeo Therapeutics. Dr. Noch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Advarra, Inc.. Dr. Noch has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Imedview, Inc.. Dr. Noch has stock in Destroke, Inc..
David N. Lieberman, MD, PhD	Dr. Lieberman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. Dr. Lieberman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taysha Gene Therapies. Dr. Lieberman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene.
Matt T. Bianchi, MD, PhD	No disclosure on file
Veronica Rivas	Veronica Rivas has nothing to disclose.
Benjamin M. Jadow, MD	Mr. Jadow has nothing to disclose.
Sneha Mantri, MD, MS, FAAN	Dr. Mantri has received personal compensation for serving as an employee of Parkinson's Foundation. Dr. Mantri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. The institution of Dr. Mantri has received research support from The Michael J Fox Foundation for Parkinson Research.
Todd Grinnell, PhD	Todd Grinnell, PhD has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc..
Amit Bhardwaj, MD	No disclosure on file
Anvita Potluri, MD	Dr. Potluri has nothing to disclose.
Yao Cheng, MBBS	Dr. Cheng has nothing to disclose.
	No disclosure on file
Tanuja Chitnis, MD, FAAN	Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche. The institution of Dr. Chitnis has received research support from Tiziana Life Sciences. The institution of Dr. Chitnis has received research support from Bristol-Myers Squibb. The institution of Dr. Chitnis has received research support from Wesley Clover.
Gregory S. Day, MD, MSc, FAAN	Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has or had stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Amgen Pharmaceuticals. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with ��ɫ��. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing ��ɫ��, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Ionis Pharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a ��ɫ��al Case Development + Presentation (video) with PeerDirect (P\S\L Group). Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development / Presentation (non-CME) with MJH Life Sciences (NeurologyLive). Dr. Day has a non-compensated relationship as a Clinical Director with Anti-NMDA Receptor Encephalitis Foundation that is relevant to AAN interests or activities.
Catherine M. Amlie-Lefond, MD, FAAN	Dr. Amlie-Lefond has nothing to disclose.
Paola Sandroni, MD, PhD, FAAN	Dr. Sandroni has nothing to disclose.
Amaal J. Starling, MD, FAAN	Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome Therapeutics. Dr. Starling has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Starling has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Miller Medical. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Salvia. Dr. Starling has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eNeura. Dr. Starling has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Woodberry Associates .
Ariane Lewis, MD, FAAN	Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Seminars in Neurology. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neuroscience.
Nikolai Gil D. Reyes, MD	Dr. Reyes has nothing to disclose.
Lokesh Saini, DM	Dr. Saini has nothing to disclose.
Angel J. Cadena Tejada, MD	Dr. Cadena Tejada has nothing to disclose.
Emily L. Evans, MD	Dr. Evans has received personal compensation for serving as an employee of EMD Serono. Dr. Evans has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Evans has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Evans has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Evans has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Evans has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Evans has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genzyme. Dr. Evans has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis.
Mayra Estrella	No disclosure on file
Hector Gonzalez	Hector Gonzalez has nothing to disclose.
Kurt Olson	Kurt Olson has received personal compensation for serving as an employee of Neurocrine Biosciences Inc. Kurt Olson has stock in Neurocrine Biosciences Inc.
Marie Y. Davis, MD, PhD	Dr. Davis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Davis has received research support from NIH NINDS. The institution of Dr. Davis has received research support from University of Washington Institute for Stem Cell and Regenerative Medicine. The institution of Dr. Davis has received research support from VA BLRD. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a study section grant reviewer with NIH. Dr. Davis has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with Parkinson's Foundation.
H. E. Hinson, MD, MCR, FAAN	Dr. Hinson has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Hinson has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association.
Parneet K. Grewal, MD	The institution of Dr. Grewal has received research support from Bristol Myer Squibb Foundation. The institution of Dr. Grewal has received research support from IPSEN Global.
Ildefonso Rodriguez-Leyva, MD, PhD, FAAN	Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Laboratorios Columbia.
Fernando D. Testai, MD, PhD, FAAN	Dr. Testai has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Testai has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Livingston, Barger, Brandt & Schroeder, L.L.P.. Dr. Testai has received publishing royalties from a publication relating to health care.
Jasmine S. Coles	Miss Coles has nothing to disclose.
Manu S. Goyal, MD	Dr. Goyal has received stock or an ownership interest from IBM. The institution of Dr. Goyal has received research support from NIH. Dr. Goyal has received personal compensation in the range of $0-$499 for serving as a Conference attendee with Capital Medical University, Shandong Madic Technology Co Ltd, Tancheng Talent Office.
Winston Chiong, MD	The institution of Dr. Chiong has received research support from the National Institutes of Health. The institution of Dr. Chiong has received research support from the Dana Foundation. Dr. Chiong has received personal compensation in the range of $500-$4,999 for serving as a member, NeuroEthics Working Group with National Institutes of Health.
Theron C. Casper, PhD	Dr. Casper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aperta Biosciences. The institution of Dr. Casper has received research support from NIH. The institution of Dr. Casper has received research support from The National Multiple Sclerosis Society. The institution of Dr. Casper has received research support from Roche. The institution of Dr. Casper has received research support from Biogen. The institution of Dr. Casper has received research support from UCB.
Karen L. Furie, MD	The institution of Dr. Furie has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen/BMS. Dr. Furie has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ/JNNP. The institution of Dr. Furie has received research support from NINDS.
Nizar Souayah, MD, FAAN	Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Kazim Jaffry	Mr. Jaffry has nothing to disclose.
Martha Daviglus	No disclosure on file
Liliana A. Ramirez-Gomez, MD, FAAN	The institution of Dr. Ramirez-Gomez has received research support from NIA-NIH.
Gregory D. Cascino, MD, FAAN	Dr. Cascino has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International League Against Epilepsy . Dr. Cascino has received intellectual property interests from a discovery or technology relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care.
Korak Sarkar, MD, MHDS, FAAN	An immediate family member of Dr. Sarkar has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Canon Medical. Dr. Sarkar has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for multiple medical-legal cases. Dr. Sarkar has a non-compensated relationship as a Senior Editor with Journal of Medical Extended Reality that is relevant to AAN interests or activities.
Luca Bartolini, MD, FAAN	Dr. Bartolini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex Pharmaceuticals. Dr. Bartolini has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��.
M.V.Padma Srivastava	No disclosure on file
Amy L. Phillips, PharmD	Amy L. Phillips, PharmD has received personal compensation for serving as an employee of EMD Serono, Inc.
Arturo I. Benitez, MD	Dr. Benitez has received personal compensation for serving as an employee of Takeda.
Ngoc Minh D. Le, MD	Dr. Le has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Le has stock in Neurona Therapeutics.
Rachel Pearson, MD	Dr. Pearson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. Dr. Pearson has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Pediatric Subspecialty Faculy. The institution of Dr. Pearson has received research support from Pediatric Subspecialty Faculty.
Heather Leduc-Pessah, MD, PhD	Dr. Leduc-Pessah has nothing to disclose.
Eric R. Eggenberger, DO, FAAN	Dr. Eggenberger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Welch-Allyn. Dr. Eggenberger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Illinois Institute of Technology (IITT). Dr. Eggenberger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx.
Kristen M. Krysko, MD	Dr. Krysko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Krysko has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Krysko has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Krysko has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Krysko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Krysko has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. The institution of Dr. Krysko has received research support from MS Society of Canda. The institution of Dr. Krysko has received research support from Roche.
Kelsey M. Smith, MD	The institution of Dr. Smith has received research support from CURE Epilepsy. The institution of Dr. Smith has received research support from UCB Pharmaceuticals.
Serena Orr, MD, MSc, FRCPC	The institution of Dr. Orr has received research support from Alberta Children's Hospital Research Institute. The institution of Dr. Orr has received research support from Canadian Institutes of Health Research. The institution of Dr. Orr has received research support from Department of Pediatrics, University of Calgary. The institution of Dr. Orr has received research support from American Headache Society. The institution of Dr. Orr has received research support from Canada First Research Excellence Fund. Dr. Orr has received publishing royalties from a publication relating to health care. Dr. Orr has a non-compensated relationship as a associate editor with Headache: The Journal of Head and Face Pain that is relevant to AAN interests or activities. Dr. Orr has a non-compensated relationship as a editorial board member with Neurology that is relevant to AAN interests or activities. Dr. Orr has a non-compensated relationship as a editorial board member with American Migraine Foundation that is relevant to AAN interests or activities.
Dan Tong Jia, MD	Dr. Jia has nothing to disclose.
Raja Hassan Imtiaz, MBBS	Dr. Imtiaz has nothing to disclose.
Sanjeev K. Bhoi, MD, MBBS	Dr. Bhoi has nothing to disclose.
Jenny Schmidt, MD	Dr. Schmidt has nothing to disclose.
Joab Chapman, MD, PhD	Dr. Chapman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mapi Pharma. Dr. Chapman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Chapman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merk Serono. The institution of Dr. Chapman has received research support from Ministry Of Industry.
Daniela N. Zohar, MD	Dr. Zohar has nothing to disclose.
Niraj Kumar, MD	Dr. Kumar has nothing to disclose.
Shibeshih Belachew, MD	Dr. Belachew has received personal compensation for serving as an employee of Biogen Inc. Dr. Belachew has received stock or an ownership interest from Biogen Inc.
John R. Absher, MD, FAAN	Dr. Absher has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rehabilitation Alternative Services, Inc.. Dr. Absher has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Butler, Means, Evins and Browne, P.A..
Nihal Satyadev, MD, MPH	Dr. Satyadev has nothing to disclose.
Christelle Nilles, MD	Dr. Nilles has received research support from French Gilles de la Tourette Association. Dr. Nilles has received research support from Owerko Centre of Alberta Children's Hospital Research Institute.
Sucharita Anand	No disclosure on file
Ana Ponciano, MD	Dr. Ponciano has nothing to disclose.
Laura Fonseca	Laura Fonseca has nothing to disclose.
Nicholas Milano, MD	Dr. Milano has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Jackson kelly.
Nuri Jacoby, MD, FAAN	Dr. Jacoby has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Jacoby has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for N/A.
Neill R. Graff-Radford, MD, FAAN	The institution of Dr. Graff-Radford has received research support from Biogen. The institution of Dr. Graff-Radford has received research support from Lilly. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Biogen. Dr. Graff-Radford has received publishing royalties from a publication relating to health care.
Paula E. Voinescu, MD	The institution of Dr. Voinescu has received research support from Epilepsy Foundation of New England. The institution of Dr. Voinescu has received research support from BWH - Connors Center. The institution of an immediate family member of Dr. Voinescu has received research support from American Epilepsy Society. Dr. Voinescu has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Phillipines League Against Epilepsy. Dr. Voinescu has received personal compensation in the range of $500-$4,999 for serving as a PhD Opponent with University of Bergen, Norway. Dr. Voinescu has a non-compensated relationship as a Board Member and Chair with My Epilepsy Story that is relevant to AAN interests or activities. Dr. Voinescu has a non-compensated relationship as a Speaker with Epilepsy Foundation that is relevant to AAN interests or activities. Dr. Voinescu has a non-compensated relationship as a Grant Reviewer with American Epilepsy Society that is relevant to AAN interests or activities. Dr. Voinescu has a non-compensated relationship as a Member of Scientific Advisory Committee with North American AED Pregnancy Registry that is relevant to AAN interests or activities.
Gary S. Gronseth, MD, FAAN	Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain & Life. Dr. Gronseth has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as a Member/EBM consultant Guideline Development Subcommittee with AAN.
Nicole Coolbaugh, Other	Ms. Coolbaugh has nothing to disclose.
Anna Janas, MD, PhD	Dr. Janas has nothing to disclose.
James F. Meschia, MD, FAAN	The institution of Dr. Meschia has received research support from NINDS. The institution of Dr. Meschia has received research support from NINDS.
Gordon Loewen	Gordon Loewen has received personal compensation for serving as an employee of Neurocrine. Gordon Loewen has received stock or an ownership interest from Neurocrine. Gordon Loewen has received intellectual property interests from a discovery or technology relating to health care.
Nolan Campbell	Nolan Campbell has received personal compensation for serving as an employee of Biogen. Nolan Campbell has stock in Biogen.
Wassim Tarraf	No disclosure on file
Philippe Major, MD	Dr. Major has nothing to disclose.
Lori Lebson	Lori Lebson has nothing to disclose.
Emmanuelle Waubant, MD, PhD, FAAN	The institution of Dr. Waubant has received research support from NIH. The institution of Dr. Waubant has received research support from NMSS. The institution of Dr. Waubant has received research support from PCORI. The institution of Dr. Waubant has received research support from Race to Erase MS. The institution of Dr. Waubant has received research support from Roche. The institution of Dr. Waubant has received research support from Department of Defense. Dr. Waubant has received publishing royalties from a publication relating to health care.
Harry Zobel, Jr., DO	Dr. Zobel has nothing to disclose.
Leslie A. Benson, MD	The institution of Dr. Benson has received research support from ROHHAD Fight, Inc. The institution of Dr. Benson has received research support from NIH. The institution of Dr. Benson has received research support from Roche/Genentech. Dr. Benson has received personal compensation in the range of $0-$499 for serving as a consultant with MA Department of public health. Dr. Benson has received personal compensation in the range of $10,000-$49,999 for serving as a consultant with National vaccine injury compensation program.
Darshil Shah, MBBS	Dr. Shah has nothing to disclose.
Tomas Kalincik	Tomas Kalincik has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Tomas Kalincik has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Health and Medical Research Council. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MS Research Australia. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Tomas Kalincik has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for WebMD Global. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for BioCSL. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. The institution of Tomas Kalincik has received research support from Biogen. The institution of Tomas Kalincik has received research support from Novartis. The institution of Tomas Kalincik has received research support from Genzyme. The institution of Tomas Kalincik has received research support from Roche. The institution of Tomas Kalincik has received research support from Celgene. The institution of Tomas Kalincik has received research support from Merck. The institution of Tomas Kalincik has received research support from MSBase Foundation. The institution of Tomas Kalincik has received research support from ARSEP and EDMUS Foundations. The institution of Tomas Kalincik has received research support from MS Research Australia. The institution of Tomas Kalincik has received research support from National Health and Medical Research Council. The institution of Tomas Kalincik has received research support from Australian Research Council. The institution of Tomas Kalincik has received research support from MS Society. The institution of Tomas Kalincik has received research support from Trish Foundation. Tomas Kalincik has a non-compensated relationship as a scientific leadership group chair with MSBase Foundation that is relevant to AAN interests or activities.
Federico J. Rodriguez-Porcel, MD, FAAN	Dr. Rodriguez-Porcel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioVie. Dr. Rodriguez-Porcel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WCG. Dr. Rodriguez-Porcel has received research support from NIH. Dr. Rodriguez-Porcel has received publishing royalties from a publication relating to health care.
Jacqueline French, MD, FAAN	Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Epilepsy Foundation. The institution of Dr. French has received research support from Epilepsy Study Consortium/ Epilepsy Foundation (Funded by UCB). The institution of Dr. French has received research support from GW/One8 Foundation/FACES. The institution of Dr. French has received research support from NINDS. The institution of Dr. French has received research support from Xenon. The institution of Dr. French has received research support from Cerevel. The institution of Dr. French has received research support from FACES. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Epilepsy Study Consortium. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Praxis. Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as a Chief Medical/Innovation Officer with Epilepsy Foundation. Dr. French has a non-compensated relationship as a Consultant with Acadia Pharmaceuticals Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Access Industries that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Acuta Capital Partners LLC that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with AFASCI Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Agrithera, Inc. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Alkermes that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Alterity Therapeutics Limited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Angelini Pharma S.p.A. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Autifony Therapeutics Limited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Axonis Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bain Capital that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Beacon Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biogen that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biohaven Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Bloom Science, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bright Minds Biosciences, Inc. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Capsidia Biotherapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Cerebral Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerecin, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Cerevel that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, SAB with Cognizance Biomarkers that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Ceribell that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cowen that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Crossject that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with EcoR1 Capital that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with EG 427 that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant, Advisory Board with Eisai that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Encoded Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant/Advisory Board with Engrail that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Epitel, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with EpiMinder that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Grin Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Harmony that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with Ionis Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with iQure Pharma, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with IQVIA that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Janssen Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Jazz Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Leal Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, with Livanova that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with London Research & Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Longboard Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Maplight Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Marinus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Medscape/Web MD that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Modulight Bio that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Montara Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Mosaica Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Neumarker that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Neumirna Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neurelis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting, Advisory Board with Neurocrine that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Neuropace that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with NeuroPro Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Neuroventis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Neurona Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, Advisory Board with Neuvarti that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Noema that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Ono Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, Advisory Board with Otsuka that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting, Advisory Board with Ovid Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Praxis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with PureTech LYT Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with QurAlis Corp that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Rapport Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Receptor Holdings, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Rivervest Venture Partners that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Sage Therapeutics, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with SK Life Science that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Stoke that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Stream Neuroscience that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Supernus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Takeda that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Taysha Gene Therapies that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with UCB, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with uniQure that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Ventus Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Vida Ventures Management that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Xenon Pharmaceuticals that is relevant to AAN interests or activities.
Surekha Dabla, MD	Dr. Dabla has nothing to disclose.
Divya Gupta, MD	Dr. Gupta has nothing to disclose.
Kamleshun Ramphul	Kamleshun Ramphul has nothing to disclose.
Lisette Arnaud-Hevi	No disclosure on file
Enrique Carrazana	Enrique Carrazana has received personal compensation for serving as an employee of Neurelis. Enrique Carrazana has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Hawaii-Biotech, CND Life Sciences, Apex Labs. Enrique Carrazana has stock in Neurelis, CND, Apex.
Susan Rowell, MD, MCR	Dr. Rowell has nothing to disclose.
Raimundo M. Brito Neto, Sr., MD	Dr. Brito Neto has nothing to disclose.
Olga Klepitskaya, MD, FAAN	Dr. Klepitskaya has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc. Dr. Klepitskaya has or had stock in Neurocrine Biosciences.
Marcela Uribe Roca	The institution of Marcela Uribe Roca has received research support from Roche.
Kristen Fisher, DO	Dr. Fisher has nothing to disclose.
Elijah M. Persad-Paisley	Mr. Persad-Paisley has nothing to disclose.
Jenny P. Garzon, MD	Dr. Garzon has nothing to disclose.
Judie B. Gutierrez, PhD	Dr. Gutierrez has received personal compensation for serving as an employee of Impel Pharmaceuticals. Dr. Gutierrez has stock in Impel Pharmaceuticals.
Birce D. Taskin, MD	Dr. Taskin has nothing to disclose.
Quynh Vo, MD	Dr. Vo has nothing to disclose.
Linda Gallo	Linda Gallo has nothing to disclose.
Nagagopal Venna, MBBS, FAAN	Dr. Venna has nothing to disclose.
Jonathon Chon Teng Chio, PhD	Dr. Chio has nothing to disclose.
Kara R. Melmed, MD	Dr. Melmed has nothing to disclose.
Victoria Q. Tay	Miss Tay has nothing to disclose.
Carla M. Francisco, MD	Dr. Francisco has nothing to disclose.
E M. Bebin, MD, FAAN	Dr. Bebin has received personal compensation for serving as an employee of Springworks Therapeutics. Dr. Bebin has received personal compensation for serving as an employee of Apertura Gene Therapy. Dr. Bebin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springworks Therapeutics. Dr. Bebin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apertura. The institution of Dr. Bebin has received research support from NINDS. The institution of Dr. Bebin has received research support from FDA Orphan Drug Program.
Julia Carlson, MD	Dr. Carlson has received publishing royalties from a publication relating to health care.
Joshua Nardin, DO	Dr. Nardin has nothing to disclose.
Timothy B. Saurer, PhD	Dr. Saurer has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. Saurer has stock in Jazz Pharmaceuticals.
Prashant Dongre, MD, MBBS	Dr. Dongre has received personal compensation for serving as an employee of UCB Inc. Dr. Dongre has stock in UCB Inc.
Muhammed Ikbal Arvas, MD	Dr. Arvas has nothing to disclose.
Alexis Angelette, MD	Dr. Angelette has nothing to disclose.
Navreet Kaur, MBBS	Dr. Kaur has nothing to disclose.
Thomas Finnegan, Jr., PhD	Dr. Finnegan has nothing to disclose.
Adeolu O. Morawo, MD	Dr. Morawo has nothing to disclose.
Shawn Moore, MD	Dr. Moore has nothing to disclose.
Marc Fischer	Marc Fischer has nothing to disclose.
Roopa Sharma, MD	Dr. Sharma has nothing to disclose.
Sharon Poisson, MD	The institution of Dr. Poisson has received research support from Biogen.
Wesley Kerr, MD, PhD	Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Lifesciences. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven Pharmaceuticals. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Kerr has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Kerr has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for QurAlis. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Pharmaceuticals. Dr. Kerr has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. The institution of Dr. Kerr has received research support from NINDS. The institution of Dr. Kerr has received research support from American Epilepsy Society. The institution of Dr. Kerr has received research support from ��ɫ��. The institution of Dr. Kerr has received research support from SK Life Science. The institution of Dr. Kerr has received research support from Biohaven Pharmaceuticals. Dr. Kerr has received publishing royalties from a publication relating to health care.
Mariana R. Brito, MD	No disclosure on file
Will McKeen, MD	Dr. McKeen has nothing to disclose.
Roberto Rodriguez, MD	Dr. Rodriguez has nothing to disclose.
Alexander Carvajal- Gonzalez, MD, PhD	Dr. Carvajal- Gonzalez has nothing to disclose.
Christopher J. Klein, MD, FAAN	Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma.
Timothy E. Lotze, MD, FAAN	Dr. Lotze has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Department of Justice VICP. The institution of Dr. Lotze has received research support from NIH. The institution of Dr. Lotze has received research support from National MS Society. The institution of Dr. Lotze has received research support from Sarepta Therapeutics. The institution of Dr. Lotze has received research support from PTC THERAPEUTICS. The institution of Dr. Lotze has received research support from Avexis. Dr. Lotze has received publishing royalties from a publication relating to health care. Dr. Lotze has received publishing royalties from a publication relating to health care.
Paresh Zanzmera, MD	Dr. Zanzmera has nothing to disclose.
Marcus Vinicius R. Pinto, MD	Dr. Pinto has nothing to disclose.
Jose Murguia Fuentes	No disclosure on file
William E. Rosenfeld, MD, FAAN	The institution of Dr. Rosenfeld has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for SK Life Science. Dr. Rosenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for SK Life Science.
Alexander Sellers, MD	Dr. Sellers has nothing to disclose.
Nicole R. Nissim, PhD	Dr. Nissim has nothing to disclose.
Luis Magalhaes	Luis Magalhaes has received personal compensation for serving as an employee of BIAL-Portela & Cª, S.A..
Eric Pappert	Eric Pappert has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc..
Rimas V. Lukas, MD	Dr. Lukas has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck and Company, Inc.. Dr. Lukas has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck and Company, Inc.. Dr. Lukas has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novocure. Dr. Lukas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for EBSCO. Dr. Lukas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink Neurology. Dr. Lukas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Lukas has received research support from BMS. The institution of Dr. Lukas has received research support from BrainUp. The institution of Dr. Lukas has received research support from National Cancer Institute. The institution of Dr. Lukas has received research support from National Cancer Institute. The institution of Dr. Lukas has received research support from Ziopharm.
Fabrizio Stocchi	Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bial, Biogen, Sunovion, Lundbeck, UCB, Zambon, Chiesi, Lusofarmaco, Abbvie, Neuroderm, Kyowa, Synegile, Roche, Britannia, Sunovion, Blue Rock. Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIAL, Zambon, Biogen, Roche, Synegile, Sunovion. Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bial, Zambon, UCB, Kyowa, Sunovion.
Judith Goldberg	No disclosure on file
Rajesh Pahwa, MD, FAAN	Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ACADIA. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Insightec. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jaaz. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fasikl. Dr. Pahwa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech. Dr. Pahwa has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Pahwa has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Photopharmics. The institution of Dr. Pahwa has received research support from Abbott. The institution of Dr. Pahwa has received research support from Abbvie. The institution of Dr. Pahwa has received research support from Biogen. The institution of Dr. Pahwa has received research support from Parkinson Foundation. The institution of Dr. Pahwa has received research support from Roche. The institution of Dr. Pahwa has received research support from Sage. The institution of Dr. Pahwa has received research support from Sun Pharma. The institution of Dr. Pahwa has received research support from Theravance. The institution of Dr. Pahwa has received research support from Neuroderm. The institution of Dr. Pahwa has received research support from Ask Bio. The institution of Dr. Pahwa has received research support from Blue Rock. The institution of Dr. Pahwa has received research support from Cerevance. The institution of Dr. Pahwa has received research support from Fasikl. The institution of Dr. Pahwa has received research support from Scion. The institution of Dr. Pahwa has received research support from UCB. The institution of Dr. Pahwa has received research support from Ono. The institution of Dr. Pahwa has received research support from Intra-cellular Therapies. The institution of Dr. Pahwa has received research support from Ask Bio. The institution of Dr. Pahwa has received research support from Michael J Fox Foundation . The institution of Dr. Pahwa has received research support from Neuron 23. The institution of Dr. Pahwa has received research support from Roche.
Samir Patel, MD, DNB, FEBN, MRCP, FRCP, FAAN	Dr. Patel has nothing to disclose.
Lauren DiSalvo, DO	Dr. DiSalvo has nothing to disclose.
Samar F. Ahmed, MD	Dr. Ahmed has nothing to disclose.
Pantelis P. Pavlakis, MD	Dr. Pavlakis has nothing to disclose.
Areej Nauman, MD	Dr. Nauman has nothing to disclose.
Shyamal C. Bir, MD	Dr. Bir has nothing to disclose.
Stacy S. Wu, MD	Dr. Wu has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc. Dr. Wu has stock in Novartis.
Sara Habib, MD	Dr. Habib has nothing to disclose.
Nancy Wang, MD	The institution of Dr. Wang has received research support from Merck. Dr. Wang has received publishing royalties from a publication relating to health care.
Holly A. Shill, MD, FAAN	Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Biogen. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KeifeRx. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis Precision Medicine. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fasikl Inc. Dr. Shill has received personal compensation in the range of $0-$499 for serving as a Consultant for Boston Scientific. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America.
Jennifer Graves, MD, PhD	Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Graves has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Graves has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MSJ. The institution of Dr. Graves has received research support from Octave. The institution of Dr. Graves has received research support from Sanofi. The institution of Dr. Graves has received research support from EMD Serono.
Tamara M. Pringsheim, MD, FAAN	The institution of Dr. Pringsheim has received research support from Canadian Institutes of Health Research. The institution of Dr. Pringsheim has received research support from Azrieli Accelerator.
Mary R. Rensel, MD, FAAN	Dr. Rensel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for genentech. Dr. Rensel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG. Dr. Rensel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Rensel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TG. Dr. Rensel has stock in Brain Fresh LLC . The institution of Dr. Rensel has received research support from NMSS. The institution of Dr. Rensel has received research support from Roche- Genentech . The institution of Dr. Rensel has received research support from Biogen.
Russell E. Bartt, MD, FAAN	Dr. Bartt has nothing to disclose.
David C. Preston, MD, FAAN	Dr. Preston has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for FBI, US Attorney, Insurance Fraud Investigative Units. Dr. Preston has received publishing royalties from a publication relating to health care.
Philip W. Tipton, MD	Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Alzheimer's Tennessee. Dr. Tipton has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Charlotte County Medical Society, Inc.
Christopher D. Geiger, MD, FAAN	Dr. Geiger has nothing to disclose.
Neishay Ayub, MD	The institution of Dr. Ayub has received research support from Brown Physicians Incorporated. The institution of Dr. Ayub has received research support from Pappitto Opportunity Connection.
Alvee Saluja, DM	Dr. Saluja has nothing to disclose.
Roger E. Kelley, Jr., MD, FAAN	Dr. Kelley has nothing to disclose.
Zehra Husain, MD	Dr. Husain has a non-compensated relationship as a member, Medical Board of Directors with Epilepsy Foundation of Eastern Pennsylvania that is relevant to AAN interests or activities.
Hong Sun, MD, PhD	Dr. Sun has received personal compensation for serving as an employee of Janssen.
Mustafa Jaffry	Mr. Jaffry has nothing to disclose.
Erin Britt, MD	Dr. Britt has nothing to disclose.
Carlos Alva-Diaz	Carlos Alva-Diaz has nothing to disclose.
Prabandh R. Buchhanolla, MBBS	Dr. Buchhanolla has nothing to disclose.
Stephen B. Shrewsbury, MD	Dr. Shrewsbury has received personal compensation for serving as an employee of Impel NeuroPharma. Dr. Shrewsbury has received stock or an ownership interest from Impel NeuroPharma.
Fernando Cendes, MD, PhD, FAAN	Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Biopharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for United Medical – Brazil. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zodiac Pharma . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eurofarma – Brazil . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology - Epilepsy. The institution of Dr. Cendes has received research support from São Paulo Research Foundation - FAPESP. The institution of Dr. Cendes has received research support from Conselho Nacional de Desenvolvimento Científico e Tecnológico - Brazil . The institution of Dr. Cendes has received research support from NIH.
Maria Elisa Samaniego, MD	Dr. Samaniego has nothing to disclose.
Hina N. Dave, MD	Dr. Dave has nothing to disclose.
John W. Rose, MD, FAAN	The institution of Dr. Rose has received research support from National Multiple Sclerosis Society. The institution of Dr. Rose has received research support from Guthy Jackson Charitable Foundation. The institution of Dr. Rose has received research support from NIH . The institution of Dr. Rose has received research support from VA. The institution of Dr. Rose has received research support from Biogen. The institution of Dr. Rose has received research support from Friends of MS. Dr. Rose has received intellectual property interests from a discovery or technology relating to health care.
Kyriakos Martakis	Kyriakos Martakis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eversana.
Jovana Lubarda	Jovana Lubarda has nothing to disclose.
Catherine W. Imossi, MD	Dr. Imossi has nothing to disclose.
Gregory Talavera	Gregory Talavera has nothing to disclose.
Jasem Y. Al-Hashel, MD	Dr. Al-Hashel has nothing to disclose.
Carly Tucci	No disclosure on file
Jason J. Sico, MD, FAAN	Dr. Sico has nothing to disclose.
Christian J. Burrell, MD	Dr. Burrell has nothing to disclose.
Joon H. Uhm, MD, FRCP(C), FAAN	Dr. Uhm has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Zai Lab.
Catherine Larochelle, MD	Dr. Larochelle has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Novartis, Sanofi-Genzyme, Alexion, EMD-Serono, FIND therapeutics, Actelion. The institution of Dr. Larochelle has received research support from Université de Montréal-CHUM.
Aravind Ganesh	No disclosure on file
Mailam Eltity	Dr. Eltity has nothing to disclose.
Fabiola Serrano-arias	No disclosure on file
Mirza Omari, MD	Dr. Omari has nothing to disclose.
Naina Murthy	Ms. Murthy has nothing to disclose.
Vishal N. Bhimarasetty, MSc	Mr. Bhimarasetty has nothing to disclose.
Deena A. Haque	Ms. Haque has nothing to disclose.
Aila Rahman	Miss Rahman has nothing to disclose.
Jeremy Abramson	Jeremy Abramson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS. Jeremy Abramson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Interius. Jeremy Abramson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seagen. Jeremy Abramson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilead. Jeremy Abramson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Jeremy Abramson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Jeremy Abramson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astra-Zeneca. Jeremy Abramson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Jeremy Abramson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Jeremy Abramson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Foresight Diagnostics. Jeremy Abramson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Miltenyi Biotec. Jeremy Abramson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BeiGene. Jeremy Abramson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. The institution of Jeremy Abramson has received research support from Allogene. The institution of Jeremy Abramson has received research support from BMS. The institution of Jeremy Abramson has received research support from Genentech. Jeremy Abramson has received research support from Cellectis. The institution of Jeremy Abramson has received research support from Merck.
Solmaz Ramezani Hashtjin, MD	Dr. Ramezani Hashtjin has nothing to disclose.
Mazieyar Azad, MD	Dr. Azad has nothing to disclose.
Michael D. Weiss, MD, FAAN	Dr. Weiss has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB-RA. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Soleo. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Weiss has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi.
Elizabeth Crabtree-Hartman, MD	Dr. Crabtree-Hartman has nothing to disclose.
Madisen L. Faulkner	Miss Faulkner has nothing to disclose.
Richard B. Lipton, MD, FAAN	Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
José María Benítez Salazar	Mr. Benítez Salazar has nothing to disclose.
Jonadab Dos Santos Silva, MD, PhD	Dr. Dos Santos Silva has nothing to disclose.
Ashok Kumar, MD	Dr. Kumar has nothing to disclose.
Jeffrey Andrews	No disclosure on file
George K. Harrold, MD	Dr. Harrold has nothing to disclose.
Melissa Armstrong, MD, MSc, FAAN, FAAN	The institution of Dr. Armstrong has received research support from National Institutes of Health. The institution of Dr. Armstrong has received research support from Florida Department of Health. The institution of Dr. Armstrong has received research support from Lewy Body Dementia Association. The institution of Dr. Armstrong has received research support from The Michael J. Fox Foundation. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Clinical Trials Consortium. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Disease Cooperative Study. Dr. Armstrong has received personal compensation in the range of $500-$4,999 for serving as a DSMB member with National Institutes of Health. Dr. Armstrong has a non-compensated relationship as a Member, Scientific Advisory Council with Lewy Body Dementia Association that is relevant to AAN interests or activities.
John Leever, MD	Dr. Leever has nothing to disclose.
Teri Schreiner, MD, MPH, FAAN	The institution of Dr. Schreiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CDC. Dr. Schreiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Schreiner has received research support from Roche Genentech.
Enrique Gomez Figueroa, MD, MSc	Dr. Gomez Figueroa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Mexico. Dr. Gomez Figueroa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca Mexico. Dr. Gomez Figueroa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson LATAM.
Pooja Jindal, Sr., MD	Dr. Jindal has nothing to disclose.
Roger J. Porter, MD, FAAN	Dr. Porter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Xenon. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Longboard. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Engrail. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axonis. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bright MInds Bioscience. Dr. Porter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Autobah. Dr. Porter has received publishing royalties from a publication relating to health care.
Simona Treidler, MD	Dr. Treidler has nothing to disclose.
Mohammed E. Abunaib, MD, MBBS	Dr. Abunaib has nothing to disclose.
Maxwell A. Greene, MD	Dr. Greene has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board Member with Dysimmune Diseases Foundation .
Mario E. Rodriguez Estrada, MD	Dr. Rodriguez Estrada has nothing to disclose.
Justyna Sarna, MD	No disclosure on file
Rahul Sasane, PhD	Dr. Sasane has received personal compensation for serving as an employee of Cerevel Therapeutics. Dr. Sasane has stock in Cerevel Therapeutics.
Luis Rafael Solís-Tarazona, MD	Mr. Solís-Tarazona has received personal compensation for serving as an employee of Novo Nordisk A/S.
Pablo Bonardo, MD	Dr. Bonardo has nothing to disclose.
Simona Eleuteri	Simona Eleuteri has received intellectual property interests from a discovery or technology relating to health care.
Antonio Arauz, MD, PhD	Dr. Arauz has nothing to disclose.
Ingemar S. Merkies, MD	No disclosure on file
Lisa M. Ford, MD, FAAN	Dr. Ford has received personal compensation for serving as an employee of Janssen . Dr. Ford has stock in Janssen.
Steven Kymes	Steven Kymes has received personal compensation for serving as an employee of Lundbeck. Steven Kymes has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Journal of Ophthalmology. Steven Kymes has received research support from Emmes Corporation.
Yanal R. Shaheen, MD	Dr. Shaheen has nothing to disclose.
Souvik Dubey	Souvik Dubey has nothing to disclose.
Karan S. Dixit, MD	Dr. Dixit has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Servier.
Clarissa L. Yasuda, MD, PhD	Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for LIBBS. Prof. Yasuda has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBOTT. Prof. Yasuda has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for LIBBS.
Florian P. Thomas, MD, PhD, MA, FAAN	Dr. Thomas has received personal compensation for serving as an employee of Hackensack Meridian Health. Dr. Thomas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MND. Dr. Thomas has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Spinal Cord Medicine. Dr. Thomas has a non-compensated relationship as a Board Member, Metro New Jersey with National MS Society that is relevant to AAN interests or activities. Dr. Thomas has a non-compensated relationship as a Board Member with American Paraplegia Society that is relevant to AAN interests or activities.
Sulena Sulena, MD	Dr. Sulena has nothing to disclose.
Vivian Chiang, MD	Dr. Chiang has nothing to disclose.
James J. Gugger, Jr., MD, PharmD	Dr. Gugger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ceribell. The institution of Dr. Gugger has received research support from American Epilepsy Society.
Robert Vann, PhD	Dr. Vann has received personal compensation for serving as an employee of Impel Neuropharma. Dr. Vann has received personal compensation for serving as an employee of Biogen.
Daniel Santos, MD	Dr. Santos has nothing to disclose.
Sutapa Ray, PhD	Dr. Ray has received personal compensation for serving as an employee of Impel Pharmaceuticals. Dr. Ray has stock in Impel Pharmaceuticals.
Mahinda Yogarajah, MD	Dr. Yogarajah has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for MEWA. Dr. Yogarajah has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Forensic Access. Dr. Yogarajah has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Eopinex. The institution of Dr. Yogarajah has received research support from MRC. Dr. Yogarajah has received publishing royalties from a publication relating to health care.
Douglas A. Wells, Jr., MD	Dr. Wells has nothing to disclose.
Deepti Zutshi, MD, FAAN	Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon pharmaceuticals. An immediate family member of Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aucta Pharmaceuticals. Dr. Zutshi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aucta.
Elizabeth Gerard, MD	Dr. Gerard has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon. The institution of Dr. Gerard has received research support from NIH/NINDS. The institution of Dr. Gerard has received research support from Xenon Pharmaceuticals. The institution of an immediate family member of Dr. Gerard has received research support from NIH. The institution of Dr. Gerard has received research support from Eisai, Inc. (via Stanford University). Dr. Gerard has received publishing royalties from a publication relating to health care.
Manasa Gunturu, MD	Dr. Gunturu has nothing to disclose.
Frédéric Loubert	Mr. Loubert has nothing to disclose.
Amir Dori, MD, PhD	Dr. Dori has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Dr. Dori has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda . Dr. Dori has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Dori has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medison Pharma. Dr. Dori has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medison Pharma. The institution of Dr. Dori has received research support from Biogen. The institution of Dr. Dori has received research support from Pfizer. The institution of Dr. Dori has received research support from Alnylam therapeutics. Dr. Dori has received intellectual property interests from a discovery or technology relating to health care.
Aisha Abdulrazaq, MBBS	Dr. Abdulrazaq has nothing to disclose.
Carlos Rodrigo Q. Vicuña	Mr. Vicuña has nothing to disclose.
Deema Sawass Najjar, MD	Dr. Sawass Najjar has nothing to disclose.
Xu Tang, DO	Dr. Tang has nothing to disclose.
Fardin Nabizadeh III	Mr. Nabizadeh has nothing to disclose.
Naiade Couto, MD	Dr. Couto has nothing to disclose.
Andrea L. Schneider, MD, PhD	Dr. Schneider has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN - Neurology.
Kristin Maher	No disclosure on file
Peyton I. Crest	Ms. Crest has nothing to disclose.
Thapat Wannarong, MD	Dr. Wannarong has nothing to disclose.
Isheeta S. Govardhan	Ms. Govardhan has nothing to disclose.
Lauren S. Talman, MD	Dr. Talman has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Oregon Federal Public Defenders Office. Dr. Talman has received personal compensation in the range of $500-$4,999 for serving as a panelist with HDSA.
Bhrugun Anisetti, MBBS	Dr. Anisetti has nothing to disclose.
Angelica G. Montilla	Miss Montilla has nothing to disclose.
Erica Kemp	Ms. Kemp has nothing to disclose.
Aaron Anandarajah	Mr. Anandarajah has nothing to disclose.
Maria Andreina Hernandez, MD	Dr. Hernandez has nothing to disclose.
Ram Balu, MD	Dr. Balu has nothing to disclose.
Ashwini Gadalay, MBBS	Dr. Gadalay has received personal compensation for serving as an employee of State university of New york, upstate medical university.
Jose L. Torres, MD	Dr. Torres has nothing to disclose.
Michael P. Skolka, MD	Dr. Skolka has nothing to disclose.
Rachel E. Glasser, MD	Dr. Triay has nothing to disclose.
Jodie Roberts, MD, MSc, FRCPC	Dr. Roberts has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Roberts has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. Dr. Roberts has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Novartis. Dr. Roberts has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with EMD Serono.
Jan-Peer Elshoff, PhD	Dr. Elshoff has nothing to disclose.
Charles S. DeCarli, MD, FAAN	Dr. DeCarli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. DeCarli has received research support from NIH.
Aiden Meyer	Mr. Meyer has received research support from Brown University - Undergraduate Teaching and Research Award.
Monroe Butler, MD, PhD	Dr. Butler has received personal compensation for serving as an employee of Biogen. Dr. Butler has stock in Biogen.
Jason Viereck, MD, PhD	Dr. Viereck has nothing to disclose.
Alessandro Tessitore	Alessandro Tessitore has nothing to disclose.
Taylor Fields	Taylor Fields has received personal compensation for serving as an employee of IntraBio Inc. Taylor Fields has stock in IntraBio. Taylor Fields has received intellectual property interests from a discovery or technology relating to health care.
Alexander Feoktistov, MD, PhD	Dr. Feoktistov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Upsher-Smith. Dr. Feoktistov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Feoktistov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Feoktistov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. Dr. Feoktistov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck. Dr. Feoktistov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven. Dr. Feoktistov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Impel.
Camille Carroll, MD	The institution of Dr. Carroll has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Dr. Carroll has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. The institution of Dr. Carroll has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial. The institution of Dr. Carroll has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Global Kinetic. The institution of Dr. Carroll has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scient. The institution of Dr. Carroll has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyowa Kirin. The institution of Dr. Carroll has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Medscape. The institution of Dr. Carroll has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bial. The institution of Dr. Carroll has received research support from Parkinson's UK. The institution of Dr. Carroll has received research support from Edmond J Safra Foundation. The institution of Dr. Carroll has received research support from Cure Parkinson's. The institution of Dr. Carroll has received research support from Parkinson's UK. The institution of Dr. Carroll has received research support from NHSX.
Muhammad Ayub, MD	Dr. Ayub has nothing to disclose.
Mohammad A. Sheikh, MBBS	Dr. Sheikh has nothing to disclose.
Xiaochun Li	No disclosure on file
Joao Vitor Mahler, MD	Dr. Mahler has received research support from The Sumaira Foundation.
Aaron W. Abrams, MD	Dr. Abrams has nothing to disclose.
Laura Naydovich, MD	Dr. Wolf has nothing to disclose.
Melinda S. Martin, PhD	Dr. Martin has received personal compensation for serving as an employee of UCB. Dr. Martin has received stock or an ownership interest from UCB.
Michael T. Mullen, MD	Dr. Mullen has received publishing royalties from a publication relating to health care.
John A. Lucas	John A. Lucas has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for American Board of Clinical Neuropsychology.
Kathryn B. Lalor, MD	The institution of Dr. Lalor has received research support from UCB. Dr. Lalor has received personal compensation in the range of $500-$4,999 for serving as a Conference Speaker with AAN. Dr. Lalor has received personal compensation in the range of $500-$4,999 for serving as a Conference Speaker with AAPC. Dr. Lalor has received personal compensation in the range of $0-$499 for serving as a DSMB Chair with UAB/NIH Grant.
Jan-Mendelt Tillema, MD	Dr. Tillema has nothing to disclose.
Giovanni Castellucci, MD, MS	Dr. Castellucci has nothing to disclose.
Samira Apostolos-Pereira	Samira Apostolos-Pereira has nothing to disclose.
Alexandra M. Livingston, DO	An immediate family member of Dr. Livingston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. An immediate family member of Dr. Livingston has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. The institution of an immediate family member of Dr. Livingston has received research support from Vertex. The institution of an immediate family member of Dr. Livingston has received research support from Roche. The institution of an immediate family member of Dr. Livingston has received research support from AstraZeneca. The institution of an immediate family member of Dr. Livingston has received research support from Enanta.
James R. Williams III, PhD	Dr. Williams has received personal compensation for serving as an employee of Biogen. Dr. Williams has received stock or an ownership interest from Biogen.
Yu-Ting Chen, MD	Dr. Chen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam.
Nasima D. Shadbehr, DO	Dr. Shadbehr has nothing to disclose.
Aashit K. Shah, MD, FAAN	Dr. Shah has stock in Abbot, Abbivie, Gilead, Johnson and Johnson, Pfizer. The institution of Dr. Shah has received research support from Xenon Pharma.
Thomas A. Nelson, MD	Dr. Nelson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Adya.
Asli Tuncer	No disclosure on file
Hannah Irvine, MD	Dr. Irvine has nothing to disclose.
Olivia Gilbert	No disclosure on file
David M. Simpson, MD, FAAN	Dr. Simpson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Dr. Simpson has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz.
Nilufer Taner, MD, PhD, FAAN	The institution of Dr. Taner has received research support from NIH.
Nicholas Lannen, MD	Dr. Lannen has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Genentech. Dr. Lannen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for TG Therapeutics. Dr. Lannen has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Horizon Theraputics.
Anam K. Shaikh	Miss Shaikh has nothing to disclose.
James W. Wheless, MD, FAAP, FACP, FAAN, FAES, FCNS, FAAN	Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Azurity. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for LivaNova. Dr. Wheless has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Wheless has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelius.
Collin Culbertson, MD	Dr. Culbertson has nothing to disclose.
Evan Riddle, PhD	Dr. Riddle has received personal compensation for serving as an employee of Biogen. Dr. Riddle has received stock or an ownership interest from Biogen.
David Cantu, PhD	Dr. Cantu has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc..
Brian W. O'Mahony, MD	Dr. O'Mahony has nothing to disclose.
Melike Cakan, MD	Dr. Cakan has nothing to disclose.
David C. Wegener, Jr., MD	Dr. Wegener has nothing to disclose.
Michael Gelfand, MD, PhD	Dr. Gelfand has received personal compensation in the range of $0-$499 for serving as a Consultant for Aquestive. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Livanova. The institution of Dr. Gelfand has received research support from Aquestive. The institution of Dr. Gelfand has received research support from Xenon. The institution of Dr. Gelfand has received research support from Cerevel. The institution of Dr. Gelfand has received research support from UNEEG. The institution of Dr. Gelfand has received research support from Livanova. The institution of Dr. Gelfand has received research support from UCB. The institution of Dr. Gelfand has received research support from SK Pharma. The institution of Dr. Gelfand has received research support from Otsuka.
Suzete N. Farias Da Guarda, MD, PhD	Prof. Farias Da Guarda has nothing to disclose.
Francis M. Filloux, MD	Dr. Filloux has nothing to disclose.
Lauren B. Krupp, MD, FAAN	Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EBIX. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman LaRoche. Dr. krupp has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for MMMK. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Patrick, Dolan, and Kaufman. Dr. krupp has received intellectual property interests from a discovery or technology relating to health care.
Paramita Saha-Chaudhuri	No disclosure on file
Julia L. Jones, PhD	Dr. Jones has received personal compensation for serving as an employee of The Medicine Group.
Georg Comes	Georg Comes has received personal compensation for serving as an employee of Merz Therapeutics GmbH.
Mostafa Jafari, MD	Dr. Jafari has nothing to disclose.
Elizabeth Seng, PhD	Dr. Seng has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Seng has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theranica. Dr. Seng has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. The institution of Dr. Seng has received research support from NCCIH. Dr. Seng has received research support from Cystic Fibrosis Foundation. The institution of Dr. Seng has received research support from American Heart Association.
Christopher Streib, MD	Dr. Streib has nothing to disclose.
Kranthi K. Mandava	Mr. Mandava has nothing to disclose.
Kaleb L. Culpepper, DO	Dr. Culpepper has nothing to disclose.
Patrick Kwan	Patrick Kwan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EDUCOM SPA. Patrick Kwan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Patrick Kwan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. The institution of Patrick Kwan has received research support from UCB. The institution of Patrick Kwan has received research support from Eisai.
Ashby Turner, MD	Dr. Turner has nothing to disclose.
Qingliang Wang, MD PhD	The institution of Dr. Wang has received research support from Maimonides Research & Development Foundation.
Anne-Liv Schulz	No disclosure on file
David Bar-Or	David Bar-Or has received intellectual property interests from a discovery or technology relating to health care.
Yolanda Wheeler	Yolanda Wheeler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Can Do MS. Yolanda Wheeler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Multiple Sclerosis Association . Yolanda Wheeler has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Multiple Sclerosis Association . Yolanda Wheeler has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Multiple Sclerosis Association . The institution of Yolanda Wheeler has received research support from National MS Society.
Koto Ishida, MD, FAAN	Dr. Ishida has received publishing royalties from a publication relating to health care.
Kathryn Fitzgerald, PhD	Dr. Fitzgerald has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Setpoint Medical. The institution of Dr. Fitzgerald has received research support from NIH. The institution of Dr. Fitzgerald has received research support from National MS Society.
Louise M. McCarthy, MB BCh BAO	Dr. McCarthy has nothing to disclose.
Ajay Goenka, MD	Dr. Goenka has nothing to disclose.
Carroline Lobo, PhD	Carroline Lobo has received personal compensation for serving as an employee of EMD Serono.
Danielle M. Hart	Miss Hart has nothing to disclose.
Gogi Kumar, MD	Dr. Kumar has nothing to disclose.
Erafat Rehim, MD	Dr. Rehim has nothing to disclose.
Florin Floricel	No disclosure on file
Moses Rodriguez, MD, FAAN	Dr. Rodriguez has received intellectual property interests from a discovery or technology relating to health care.
Landon Oetjen, MD, PhD	Dr. Oetjen has nothing to disclose.
Astrid Scheschonka	No disclosure on file
Jeanne Feuerstein, MD	Dr. Feuerstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceutical. The institution of Dr. Feuerstein has received research support from Mowry Fund Grant. The institution of Dr. Feuerstein has received research support from Davis Phinney. Dr. Feuerstein has received research support from MJFF - Write Now Initiative. Dr. Feuerstein has received personal compensation in the range of $500-$4,999 for serving as a Parkinson's Expert for Legal Case with Keating Wagner Palidori. Dr. Feuerstein has received personal compensation in the range of $100,000-$499,999 for serving as a Attending Neurologist with VAMC. Dr. Feuerstein has received personal compensation in the range of $100,000-$499,999 for serving as a Assistant Professor of Neurology with University of Colorado.
Omar Elsekaily, MBBS	Dr. Elsekaily has nothing to disclose.
Samuel Frank, MD	Dr. Frank has nothing to disclose.
Miguela Marie A. Senga, MD	Dr. Senga has nothing to disclose.
Angie El-said, MD	Ms. El-said has nothing to disclose.
Olga Garcia-Bedoya	No disclosure on file
Steven P. Sparagana, MD, FAAN	Dr. Sparagana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwich Biosciences. Dr. Sparagana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nobelpharma. The institution of Dr. Sparagana has received research support from Greenwich Biosciences. The institution of Dr. Sparagana has received research support from Tuberous Sclerosis Alliance. The institution of Dr. Sparagana has received research support from Novartis. Dr. Sparagana has a non-compensated relationship as a Professional Advisory Board Member, committee member with Tuberous Sclerosis Alliance that is relevant to AAN interests or activities.
David K. Simon, MD, PhD	Dr. Simon has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Bial Biotech. An immediate family member of Dr. Simon has stock in Biogen. The institution of Dr. Simon has received research support from Weston Brain Institute. The institution of Dr. Simon has received research support from NIH. The institution of Dr. Simon has received research support from Neuraly. Dr. Simon has received personal compensation in the range of $5,000-$9,999 for serving as a Steering Committee Member: SPARK clinical study with Biogen. Dr. Simon has received personal compensation in the range of $500-$4,999 for serving as a Steering Committee Member: NILO-PD clinical study with Michael J Fox Foundation.
Judy Opao, MD	Dr. Opao has nothing to disclose.
Ricardo C. Reisin, MD	Dr. Reisin has nothing to disclose.
Danny Samkutty, MD	Dr. Samkutty has nothing to disclose.
Lara Carvalho de Oliveira	Mrs. Carvalho de Oliveira has nothing to disclose.
Adam Ferguson	The institution of Adam Ferguson has received research support from NIH. The institution of Adam Ferguson has received research support from VA. The institution of Adam Ferguson has received research support from DoD. The institution of Adam Ferguson has received research support from Wings for Life Foundation. The institution of Adam Ferguson has received research support from Craig H Neilsen Foundation. Adam Ferguson has received intellectual property interests from a discovery or technology relating to health care.
Sheena K. Aurora, MD	Dr. Aurora has received personal compensation for serving as an employee of Alzheimer's Association.
Shalin D. Shah, MD	Dr. Shah has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Eris.
Ankur Nayyar, MD	Dr. Nayyar has nothing to disclose.
Jose J. Flores-Rivera, MD	Dr. Flores-Rivera has nothing to disclose.
Myrna Cardiel, MD	Dr. Cardiel has nothing to disclose.
Malak AlMojel, MD	Dr. AlMojel has nothing to disclose.
Luis Molina Carrion, MD	Dr. Molina Carrion has nothing to disclose.
Alyssa Bowling	Ms. Bowling has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc.
Helena Gama	Helena Gama has received personal compensation for serving as an employee of Bial-Portela & Cª S.A..
Tyrone Coleman, MD	Mr. Coleman has nothing to disclose.
María Cedeño-Bruzual, MD	Dr. Cedeño-Bruzual has nothing to disclose.
Shelly D. Ozark, MD	Dr. Ozark has nothing to disclose.
David E. Kahn, MD	An immediate family member of Dr. Kahn has received personal compensation for serving as an employee of Essai.
Rafaela Farias Vidigal Nascimento, MD	Miss Nascimento has nothing to disclose.
Jorg Wissel	No disclosure on file
Alice Edwards, DO	The institution of Dr. Rutatangwa has received research support from NIH.
Kereisha Donegal, MD	Dr. Donegal has nothing to disclose.
Jose L. Ruiz-Sandoval, MD	Dr. Ruiz-Sandoval has nothing to disclose.
Jeffrey W. Britton, MD, FAAN	Dr. Britton has received personal compensation in the range of $0-$499 for serving as a Online course with American Clinical Neurophysiology Society.
Aaron Desai, MD, MBBS	Dr. Desai has nothing to disclose.
Michael Waltz	No disclosure on file
Jaime Kulisevsky, MD, PhD	Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Esteve. Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Britannia. Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AC Immune. Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial. Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zambon. Dr. Kulisevsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Britannia.
Mark Gorman, MD	The institution of Dr. Gorman has received research support from Pfizer. The institution of Dr. Gorman has received research support from Roche / Genetech .
Stewart J. Tepper, MD	Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aeon. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aruene. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atheneum. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Axsome Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Becker Pharmaceutical Consulting. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clearview Healhcare Partners. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CoolTech. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CRG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Decision Resources. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Defined Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DRG. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ExpertConnect. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FCB Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fenix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Advances. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Science Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HMP Communications. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Impel. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InteractiveForums. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Keyquest. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Krog and Partners. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Magnolia Innovation. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJH Holdings. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurolief. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for P Value Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pain Insights Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Palion Medical. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pulmatrix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Putnam Associates. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SAI MedPartners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Slingshot Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spherix Global Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strategy Inc. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for System Analytic. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Taylor and Francis. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Trinity Partners. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UnityHA. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for XOC. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Click Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Miravo. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurofront Therapeutics. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rehaler. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Tepper has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Pfizer. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alphasights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Perfood. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Scilex. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communication. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tegus. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catch Therapeutics. Dr. Tepper has received personal compensation in the range of $0-$499 for serving as a Consultant for DocDelta. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dr Reddy's. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FCB Health. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gilmartin Capital. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Initiator Pharma. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Magellan Health. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Nocira. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Slingshot Insights. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Third Bridge. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tonix. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vial . Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for DocDelta. The institution of Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bausch Health. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Dr Reddy's. The institution of Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ClickTherapeutics. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CoolTech. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Miravo Healthcare. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pulmatrix. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Satsuma. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Tepper has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Pfizer. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Scilex. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Tonix. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Dr Reddy's. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Anneal. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Axsome. The institution of Dr. Tepper has received research support from Abbvie. The institution of Dr. Tepper has received research support from Aeon. The institution of Dr. Tepper has received research support from Amgen. The institution of Dr. Tepper has received research support from Annovis. The institution of Dr. Tepper has received research support from Axsome. The institution of Dr. Tepper has received research support from Cassava. The institution of Dr. Tepper has received research support from Cognition. The institution of Dr. Tepper has received research support from Eli Lilly. The institution of Dr. Tepper has received research support from Inibikase. The institution of Dr. Tepper has received research support from Ipsen. The institution of Dr. Tepper has received research support from Lundbeck. The institution of Dr. Tepper has received research support from Merz. The institution of Dr. Tepper has received research support from Pfizer. The institution of Dr. Tepper has received research support from PrecisionMed. The institution of Dr. Tepper has received research support from Revance. The institution of Dr. Tepper has received research support from Suven. The institution of Dr. Tepper has received research support from UCB. The institution of Dr. Tepper has received research support from Biohaven. The institution of Dr. Tepper has received research support from Johnson and Johnson/Intracellular. The institution of Dr. Tepper has received research support from Karuna. The institution of Dr. Tepper has received research support from Neurocrine. Dr. Tepper has received publishing royalties from a publication relating to health care. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a CME Speaker with Diamond Headache Clinic. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical Learning Institute Peerview. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Medical ��ɫ�� Speakers Network. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a CME Speaker with Miller Medical Communications. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Physicians' ��ɫ�� Resource. Dr. Tepper has received personal compensation in the range of $10,000-$49,999 for serving as a CME Speaker with WebMD/Medscape. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with American Headache Society. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with Vindico Medical ��ɫ��. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with HMP Global. Dr. Tepper has received personal compensation in the range of $500-$4,999 for serving as a CMe speaker with Medical Learning Institute Peerview. Dr. Tepper has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with Consortium for Research ��ɫ�� Social Awareness and Training In Neurosciences.
Francisco Caiza Zambrano, MD	Dr. Caiza Zambrano has nothing to disclose.
Carmen Isasi	The institution of Carmen Isasi has received research support from NIH.
Michael Strupp, MD, DO, FAAN	Dr. Strupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertify. Dr. Strupp has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for IntraBio. Dr. Strupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vifor, Frisenius, CH. Dr. Strupp has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Strupp has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers. Dr. Strupp has stock in IntraBio.
Patrick Fagan, MD	Dr. Fagan has nothing to disclose.
Tomoko Kitago, MD	Dr. Kitago has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MindMaze. The institution of Dr. Kitago has received research support from American Speech-Language Hearing Foundation. The institution of Dr. Kitago has received research support from National Institutes of Health.
Hamada H. Altalib, DO	The institution of Dr. Altalib has received research support from UCB. The institution of Dr. Altalib has received research support from DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS.
Kore K. Liow, MD, FACP	The institution of Dr. Liow has received research support from UCB. The institution of Dr. Liow has received research support from Livanova. The institution of Dr. Liow has received research support from Biogen. The institution of Dr. Liow has received research support from Novartis. The institution of Dr. Liow has received research support from Eisai. The institution of Dr. Liow has received research support from Engage Therapeutics. The institution of Dr. Liow has received research support from SK Lifescience. The institution of Dr. Liow has received research support from Cerevel. The institution of Dr. Liow has received research support from Xenon. The institution of Dr. Liow has received research support from NeuroDerm. The institution of Dr. Liow has received research support from Avanir. The institution of Dr. Liow has received research support from Annovis. The institution of Dr. Liow has received research support from Acadia. The institution of Dr. Liow has received research support from Prothena. The institution of Dr. Liow has received research support from SAGE. The institution of Dr. Liow has received research support from Annovis. The institution of Dr. Liow has received research support from Cyclerion.
Katelyn Stebbins	Miss Stebbins has nothing to disclose.
Todd Kunkel, Other	Mr. Kunkel has received personal compensation for serving as an employee of Collegium Pharmaceutical . Mr. Kunkel has stock in Collegium .
Barbara Voetsch, MD, PhD	The institution of Dr. Voetsch has received research support from NIH StrokeNet . Dr. Voetsch has received publishing royalties from a publication relating to health care. Dr. Voetsch has received personal compensation in the range of $500-$4,999 for serving as a International Stroke Conference attendee (travel-related expenses) with AHA/ASA. Dr. Voetsch has a non-compensated relationship as a member of the Massachusetts Systems of Care Workgroup with AHA/ASA that is relevant to AAN interests or activities.
Tracy-Shi Zhang Fang, PhD	Dr. Fang has nothing to disclose.
Sean Stern	Mr. Stern has received personal compensation for serving as an employee of SK Life Science.
Gabriel Da Silva Avellar, MD	No disclosure on file
Anne T. Berg, PhD	Dr. Berg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven. Dr. Berg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Berg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Encoded. Dr. Berg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biomarin. The institution of Dr. Berg has received research support from FamilieSCN2A Foundation.
Melody Badii, MD	Dr. Badii has nothing to disclose.
Ricka Messer, MD	The institution of Dr. Messer has received research support from Ultragenyx Pharmaceutical Inc. Dr. Messer has a non-compensated relationship as a Chair of the Pediatric Neurology Specialty Steering Board with Epic that is relevant to AAN interests or activities. Dr. Messer has a non-compensated relationship as a Member of the AAN Quality Informatics Subcommittee with ��ɫ�� that is relevant to AAN interests or activities.
Tyler Lasky	Tyler Lasky has received personal compensation for serving as an employee of Biogen. Tyler Lasky has stock in Biogen.
Steve Arcona, PhD	Dr. Arcona has received personal compensation for serving as an employee of Cerevel. Dr. Arcona has stock in Cerevel.
Ricardo Murguia Fuentes, MD	Dr. Murguia Fuentes has nothing to disclose.
Andrea Kuehn	Andrea Kuehn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Andrea Kuehn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific.
Nazire P. Acar Ozen, MD	Dr. Acar Ozen has nothing to disclose.
Ahmer Asif, MD	Dr. Asif has nothing to disclose.
Nicole Bou Rjeily, MD	Dr. Bou Rjeily has nothing to disclose.
Yi-Bin Chen	No disclosure on file
Jyoti Garg, MD	Dr. Garg has nothing to disclose.
Tamara Strohm, MD	Dr. Strohm has nothing to disclose.
Vijay Sardana, MD	No disclosure on file
Tatiana T. Bremova-Ertl, MD, PhD	Dr. Bremova-Ertl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intrabio. The institution of Dr. Bremova-Ertl has received research support from InnoSuisse. Dr. Bremova-Ertl has received research support from Baasch-Medicus.
Lana Zhovtis Ryerson, MD, FAAN	Dr. Zhovtis Ryerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Zhovtis Ryerson has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Anthony E. Lang, MD, FAAN	Dr. Lang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AbbVie, Amylyx, Aprinoia, Biogen, BioAdvance, Biohaven, BioVie, BlueRock, BMS, Denali, Janssen, Lilly, Pharma 2B, Sun Pharma, and UCB. Dr. Lang has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for medicolegal cases related to paraquat. The institution of Dr. Lang has received research support from AbbVie. Dr. Lang has received intellectual property interests from a discovery or technology relating to health care. Dr. Lang has received publishing royalties from a publication relating to health care.
Danielle Sandsmark, MD	The institution of Dr. Sandsmark has received research support from NINDS. The institution of Dr. Sandsmark has received research support from BrainBox Solutions Inc. The institution of Dr. Sandsmark has received research support from Department of Defense.
Samy M. Guirguis, MD	No disclosure on file
Kiran Bala, MD, MBBS	Dr. Bala has nothing to disclose.
Page B. Pennell, MD, FAAN	The institution of Dr. Pennell has received research support from NIH.
Robert T. Wechsler, MD, PhD, FAAN	The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Otsuka. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aquestive. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Engage. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eisai. The institution of Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eliem. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epalex. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Engrail. The institution of Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Equilibre. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rapport. The institution of Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurona. Dr. Wechsler has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurelis. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Sunovion. Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Greenwich/Jazz. Dr. Wechsler has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eisai. Dr. Wechsler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aquestive. Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science. Dr. Wechsler has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Epilepsy Studies Consortium. Dr. Wechsler has a non-compensated relationship as a Board President with Epilepsy Foundation of Idaho that is relevant to AAN interests or activities.
Rhoda Au, PhD	Dr. Au has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Au has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Au has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Au has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NovoNordisk. Dr. Au has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GSK. Dr. Au has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Dr. Au has received publishing royalties from a publication relating to health care. Dr. Au has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant with Davos Alzheimer's Collaborative. Dr. Au has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant with High Lantern.
Scott Patten, PhD	Dr. Patten has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Canadian Psychiatric Association. Dr. Patten has received publishing royalties from a publication relating to health care.
Nauman Tariq, MD	Dr. Tariq has received personal compensation for serving as an employee of NC neurological society .
Kristin Salottolo, MPH	Ms. Salottolo has nothing to disclose.
Nazanin Sheibani, MD	Dr. Sheibani has nothing to disclose.
Teresita Corona Vazquez	No disclosure on file
Alizeh Shamshad	Ms. Shamshad has nothing to disclose.
Philip Sjostedt	Philip Sjostedt has received personal compensation for serving as an employee of The Medicine Group. Philip Sjostedt has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for SyNeBio.
Mahesh Chikkannaiah, MD	Dr. Chikkannaiah has nothing to disclose.
Roger Cady, MD	Dr. Cady has received personal compensation for serving as an employee of Lundbeck. Dr. Cady has stock in Alder Biopharmaceutical.
Susie Sinks	No disclosure on file
Samhita Panda, MD, DM	Dr. Panda has nothing to disclose.
Jianwen Cai	No disclosure on file
Rohit Bhatia, MD, MBBS, DM	Dr. Bhatia has nothing to disclose.
Beatriz Costa	Miss Costa has nothing to disclose.
William Ondo, MD	Dr. Ondo has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurocrine. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ACADIA. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. The institution of Dr. Ondo has received research support from Cerevel. The institution of Dr. Ondo has received research support from SCION. The institution of Dr. Ondo has received research support from Harmony. Dr. Ondo has received publishing royalties from a publication relating to health care.
Butchi Raju Garuda, MD, FAAN	Dr. Garuda has nothing to disclose.
Drishti Shah, PhD	Dr. Shah has received personal compensation for serving as an employee of Takeda.
Juan C. Ayala Alvarez, MD	Dr. Ayala Alvarez has nothing to disclose.
Laura A. Kirkpatrick, MD	The institution of Dr. Kirkpatrick has received research support from American Epilepsy Society. The institution of Dr. Kirkpatrick has received research support from Child Neurologist Career Development Program. The institution of Dr. Kirkpatrick has received research support from Child Neurology Foundation. The institution of Dr. Kirkpatrick has received research support from Rosenau Family Research Foundation. The institution of Dr. Kirkpatrick has received research support from Society of Family Planning. The institution of Dr. Kirkpatrick has received research support from Pediatric Epilepsy Research Consortium. Dr. Kirkpatrick has received personal compensation in the range of $500-$4,999 for serving as a Meeting Attendee with One8 Foundation. Dr. Kirkpatrick has received personal compensation in the range of $500-$4,999 for serving as a Meeting Attendee with Brigham and Women's Hospital. Dr. Kirkpatrick has received personal compensation in the range of $0-$499 for serving as a Meeting Attendee with Pediatric Epilepsy Research Consortium. Dr. Kirkpatrick has received personal compensation in the range of $0-$499 for serving as a Grant reviewer with Society of Family Planning. Dr. Kirkpatrick has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Norton Children's Hospital. Dr. Kirkpatrick has a non-compensated relationship as a Board of Directors member with My Epilepsy Story that is relevant to AAN interests or activities.
Sarah Anthony, Other	Ms. Anthony has nothing to disclose.
Abdullahi Musa Adamu, MBBS	Dr. Adamu has nothing to disclose.
Ariana Stickel	No disclosure on file
Gregory S. Aaen, MD	Dr. Aaen has nothing to disclose.
Kristi M. Anderson, DO	Dr. Anderson has nothing to disclose.
Kelsey Hillhouse, MD	Dr. Carr has nothing to disclose.
Fazila Aseem, MD, MPH	Dr. Aseem has nothing to disclose.
Jorge L. Morales, MD	Dr. Morales has nothing to disclose.
Guilherme D. Silva, MD	Dr. SILVA has nothing to disclose.
Mark R. Keezer, MD, PhD	The institution of Dr. Keezer has received research support from TD Bank. The institution of Dr. Keezer has received research support from Savoy Foundation. The institution of Dr. Keezer has received research support from Canadian Institutes of Health Research. The institution of Dr. Keezer has received research support from Fonds de Recherche Québec Santé. The institution of Dr. Keezer has received research support from Canadian Institutes of Health Research. The institution of Dr. Keezer has received research support from Precision Child Health Partnership Catalyst Program.
Audrey Gabelle, MD	No disclosure on file
Deepti Vibha, MD	Dr. Vibha has nothing to disclose.
Clarence Wade	Clarence Wade has nothing to disclose.
Mattia Rosso, MD	Dr. Rosso has nothing to disclose.
Preet M. Varade, MD	Dr. Varade has nothing to disclose.
Marina K. Alvim	Dr. Alvim has nothing to disclose.
Johnny Chen, Other	Mr. Chen has nothing to disclose.
Tracy Dixon-Salazar, PhD	Dr. Dixon-Salazar has received personal compensation for serving as an employee of Lennox-Gastaut Syndrome (LGS) Foundation. Dr. Dixon-Salazar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuelis.
Alissa A. Thomas, MD, FAAN	The institution of Dr. Thomas has received research support from Novocure. The institution of Dr. Thomas has received research support from Ono Pharmaceuticals.
Luciana V. Leon Cejas, MD	Dr. Leon Cejas has nothing to disclose.
David Daniel, MD	Dr. Daniel has nothing to disclose.
Lucas S. Silva, MD	Dr. Silva has nothing to disclose.
Sandra Badial	Ms. Badial has nothing to disclose.
Nathan P. Staff, MD, PhD, FAAN	Dr. Staff has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stem Cell Research & Therapy. Dr. Staff has received research support from National Institutes of Health.
Hassan Jassim Al Hail, MD, FAAN	Dr. Al Hail has nothing to disclose.
Nikita Shukla, MD	The institution of Dr. Shukla has received research support from Roche.
Eduardo Nobile-Orazio, MD, PhD, FAAN	Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX, Belgium. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LFB, France. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche, Switzerland. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen, USA. The institution of Dr. Nobile-Orazio has received research support from Takeda/Shire.
Seo Youn Chang	Miss Chang has nothing to disclose.
Katherine A. Zarroli, MD	Dr. Zarroli has nothing to disclose.
Atef Kokash, DO	Dr. Kokash has nothing to disclose.
Michael Reznik, MD	Dr. Reznik has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Morrison Mahoney. The institution of Dr. Reznik has received research support from NIDUS.
Stuart H. Isaacson, MD, FAAN	The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for acorda. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for adamas. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neuroderm. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for amneal. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for adamas. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acadia. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie.
Rahul Damani	Rahul Damani has nothing to disclose.
Elizabeth B. Edwards	Miss Edwards has nothing to disclose.
Jethro Hu, MD	Dr. Hu has nothing to disclose.
Ali H. Abusrair, MD	Dr. Abusrair has nothing to disclose.
Karen Smirnakis	No disclosure on file
Luis Guedes, MD	Mr. Guedes has received personal compensation for serving as an employee of BIAL - Portela & C.ª, S.A..
Shannon McWeeney	No disclosure on file
Mathew Gregoski	No disclosure on file
Luz Antonella A. Díaz Ledesma	Miss Díaz Ledesma has nothing to disclose.
Boulenouar Mesraoua, MD, FAAN	Dr. Mesraoua has nothing to disclose.
Raed Alroughani, MD, FAAN	Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, AstraZeneca, Novartis, Merck, Roche, Sanofi. Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AstraZeneca, Biogen, Novartis, Merck, Roche, Sanofi.
Carlos De la Garza, MD	Dr. De la Garza has nothing to disclose.
Clover Youn, MD	Dr. Youn has nothing to disclose.
Peter C. Mabie, MD	Dr. Mabie has nothing to disclose.
Renuka Verma	Renuka Verma has nothing to disclose.
Francisco Rocha	Francisco Rocha has received personal compensation for serving as an employee of BIAL - Portela.
Nasser Mohammed, MBBS	Dr. Mohammed has nothing to disclose.
Soe S. Mar, MD, FAAN	The institution of Dr. Mar has received research support from NIH.
Ryan Metzger, PhD	An immediate family member of Dr. Metzger has received personal compensation for serving as an employee of Neurocrine Biosciences. Dr. Metzger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Interpro Bioscience. An immediate family member of Dr. Metzger has stock in Ascendis. An immediate family member of Dr. Metzger has stock in Neurocrine Biosciences.
Sherry Danese	No disclosure on file
Pradeep Kumar Gunasekaran	No disclosure on file
Lalitha Sivaswamy, MD	Dr. Sivaswamy has nothing to disclose.
Cleo Zarina A. Reyes, MD	Dr. Reyes has nothing to disclose.
Ezequiel Gleichgerrcht, MD	Dr. Gleichgerrcht has nothing to disclose.
Italo Karmann Aventurato, MD	Dr. Karmann Aventurato has received research support from Coordenadoria de Aperfeiçoamento de Pessoal de Ensino Superior (CAPES). Dr. Karmann Aventurato has received research support from Fundação de Amparo a Pesquisa do Estado de São Paulo (FAPESP).
Mandip S. Dhamoon, MD, MPH	Dr. Dhamoon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Faegre Baker Daniels LLP. Dr. Dhamoon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Wellstar Health System Inc. Dr. Dhamoon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Fabiani Cohen & Hall, LLP. Dr. Dhamoon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Kramer, Dillof, Livingston & Moore. Dr. Dhamoon has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Robins Kaplan. Dr. Dhamoon has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Parker Waichman LLP. Dr. Dhamoon has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Heidell, Pittoni, Murphy & Bach, LLP.
Abhay Ranjan	Abhay Ranjan has nothing to disclose.
Gian C. Rossi, DO	Dr. Rossi has nothing to disclose.
Lisa Hobson-Webb, MD, FAAN	Dr. Hobson-Webb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Therapeutics. Dr. Hobson-Webb has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion . The institution of Dr. Hobson-Webb has received research support from Abcuro. The institution of Dr. Hobson-Webb has received research support from Avidity. Dr. Hobson-Webb has received personal compensation in the range of $500-$4,999 for serving as a ��ɫ��al Talk - not speaker bureau with Takeda. Dr. Hobson-Webb has received personal compensation in the range of $500-$4,999 for serving as a ��ɫ��al Talk - not speaker bureau with CSL Behring.
Xiao Michelle Androulakis, MD	The institution of Dr. Androulakis has received research support from VA rehabilitation research .
Leigh E. Charvet, PhD	Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Healthcare. Dr. Charvet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for YBrain. Dr. Charvet has stock in Johnson&Johnson.
Mancia M. Ko, Other	Dr. Ko has received personal compensation for serving as an employee of Collegium Pharmaceutical.
Muhannad Seyam, MD	Dr. Seyam has nothing to disclose.
Melika S. Jameie, MD	Dr. Jameie has nothing to disclose.
Farah Wahbeh, MD	Ms. Wahbeh has nothing to disclose.
Julie Hviid Hahn-Pedersen	Julie Hviid Hahn-Pedersen has received personal compensation for serving as an employee of Novo Nordisk A/S. Julie Hviid Hahn-Pedersen has stock in Novo Nordisk A/S.
Lauren Koffman, DO, MS	Dr. Koffman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Law Firm. Dr. Koffman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Walters Kluwer.
Nakul Katyal, MD	Dr. Katyal has nothing to disclose.
Sharon Cohen, MD	Dr. Cohen has nothing to disclose.
David G. Vossler, MD, FAAN	Dr. Vossler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Longboard Pharmaceuticals. Dr. Vossler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Xenon Pharmaceuticals. Dr. Vossler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science. The institution of Dr. Vossler has received research support from Xenon Pharmaceuticals. The institution of Dr. Vossler has received research support from Longboard Pharmaceuticals. Dr. Vossler has received publishing royalties from a publication relating to health care.
Ashley Santilli, MD	Dr. Santilli has nothing to disclose.
Vijayakumar Javalkar, MD, MCh, FAAN	Dr. Javalkar has nothing to disclose.
Isabel Arrillaga-Romany, MD	Dr. Arrillaga-Romany has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim. The institution of Dr. Arrillaga-Romany has received research support from Astex Pharmaceuticals. The institution of Dr. Arrillaga-Romany has received research support from Gsk.
Leonardo Pipek, MD	Dr. Pipek has nothing to disclose.
Chris M. Kozma	No disclosure on file
David P. Lerner, MD	Dr. Lerner has received publishing royalties from a publication relating to health care.
Heidi L. Henninger, MD, FAAN	Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB.
John F. Foley, MD, FAAN	The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave. Dr. Foley has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics . The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Foley has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Foley has stock in InterPRO Bioscience. The institution of Dr. Foley has received research support from Biogen. The institution of Dr. Foley has received research support from Novartis. The institution of Dr. Foley has received research support from Octave. The institution of Dr. Foley has received research support from Genentech. The institution of Dr. Foley has received research support from Imstem. The institution of Dr. Foley has received research support from Aegir.
Sorleen Trevino, MD	Dr. Trevino has nothing to disclose.
Hesham Masoud, MD	Dr. Masoud has nothing to disclose.
Shadi Yaghi, MD	Dr. Yaghi has nothing to disclose.
Abbie Chan	Miss Chan has nothing to disclose.
Farhad Sahebkar-Moghaddam, MD	Dr. Sahebkar-Moghaddam has received personal compensation for serving as an employee of Jazz pharmaceuticals. Dr. Sahebkar-Moghaddam has stock in Jazz pharmaceuticals.
David R. Cornblath, MD	Dr. Cornblath has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Octapharma. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Cornblath has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Cornblath has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cigna. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Anavex. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hansa. Dr. Cornblath has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MPTP. Dr. Cornblath has received intellectual property interests from a discovery or technology relating to health care.
Daniah Shamim, MD	Dr. Shamim has nothing to disclose.
Hayden W. Hall, DO	Dr. Hall has nothing to disclose.
Connor Goo	Mr. Goo has nothing to disclose.
Michelle X. Lu	Miss Lu has nothing to disclose.
Michele Persico, MD	Dr. Persico has nothing to disclose.
Ilya Kister, MD, FAAN	Dr. Kister has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech-Roche. Dr. Kister has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Kister has received research support from Genentech. The institution of Dr. Kister has received research support from Novartis. Dr. Kister has received publishing royalties from a publication relating to health care.
Sailaja Sanikommu, MBBS	Dr. Sanikommu has nothing to disclose.
Carole Drexel	Carole Drexel has nothing to disclose.
Karthik Bodhinathan, PhD	Dr. Bodhinathan has received personal compensation for serving as an employee of TG Therapeutics. Dr. Bodhinathan has stock in TG Therapeutics.
Kun-Wei Song, MD	Dr. Song has nothing to disclose.
M. S. Perry, MD	Dr. Perry has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for stoke therapeutics. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Marinus. Dr. Perry has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for jazz pharmaceuticals. Dr. Perry has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for pyros. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for azurity. Dr. Perry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Perry has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoke Therapeutics. Dr. Perry has stock in Praxis Precision Medicine. Dr. Perry has stock in Biohaven. Dr. Perry has stock in Rapport. Dr. Perry has stock in Alto Neurosciences. Dr. Perry has a non-compensated relationship as a president with child neurology foundation that is relevant to AAN interests or activities. Dr. Perry has a non-compensated relationship as a President with Pediatric Epilepsy Research Consortium that is relevant to AAN interests or activities.
Gabriela Trifan, MD	Dr. Trifan has nothing to disclose.
Rana Karabudak, MD	Dr. Karabudak has nothing to disclose.
Pierpaolo Turcano, MD	Dr. Turcano has nothing to disclose.
Obiefuna A. Nwabueze, MD	Dr. Nwabueze has nothing to disclose.
Dwight Barry	No disclosure on file
Inder Puri, MD, MBBS	Dr. Puri has nothing to disclose.
Steve Chung, MD, FAAN	The institution of Dr. Chung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ucb pharma. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Life sciences. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eisai. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for eisai. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for ucb. Dr. Chung has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK Life sciences. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for sunovion.
Melissa Lamar	No disclosure on file
Gayane R. Melikyan, MD, FAAN	Dr. Melikyan has nothing to disclose.
Suemin J. Yoon, MD	Dr. Yoon has nothing to disclose.
Ali Mahta, MD	Dr. Mahta has received research support from Brown University Health.
Brian Nahed	No disclosure on file
Michelle P. Lin, CRC	Dr. Lin has nothing to disclose.
Janice Wong, MD	Dr. Wong has received personal compensation for serving as an employee of Janssen Research & Development. Dr. Wong has received personal compensation for serving as an employee of Biogen. Dr. Wong has stock in Biogen. Dr. Wong has stock in Janssen Research & Development.
Nasrin Rahimian, MD	Dr. Rahimian has nothing to disclose.
Jorg Dietrich, MD, PhD, FAAN	Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Pharmaceuticals. Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson. Dr. Dietrich has received publishing royalties from a publication relating to health care.
Varina Boerwinkle, MD	Dr. Boerwinkle has nothing to disclose.
Kaitlin Seibert, MD	Dr. Seibert has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Seibert has received research support from Retirement Research Foundation. The institution of Dr. Seibert has received research support from Center for Healthcare Delivery Science and Innovation. Dr. Seibert has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Eli Lilly. Dr. Seibert has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with NeurologyLive.
Yakeel Quiroz, PhD	Dr. Quiroz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Quiroz has received research support from National Institutes of Health. The institution of Dr. Quiroz has received research support from Alzheimer's Association. The institution of Dr. Quiroz has received research support from Mass General Hospital Executive Committee on Research (ECOR). Dr. Quiroz has received intellectual property interests from a discovery or technology relating to health care.
Hisham Salahuddin, MD	Dr. Salahuddin has nothing to disclose.
J. R. McFaline-Figueroa, MD, PhD	The institution of Dr. McFaline-Figueroa has received research support from National Brain Tumor Society. The institution of Dr. McFaline-Figueroa has received research support from National Institutes of Health. The institution of Dr. McFaline-Figueroa has received research support from Robert Wood Johnson Foundation. Dr. McFaline-Figueroa has received publishing royalties from a publication relating to health care. Dr. McFaline-Figueroa has received publishing royalties from a publication relating to health care.
Jeffrey Kuerbitz, PhD	Dr. Kuerbitz has nothing to disclose.
Lindsay Tetreault, MD, PhD	Dr. Tetreault has nothing to disclose.
Shambaditya Das, Jr., MD, MBBS	Dr. Das has nothing to disclose.
Ali A. Habib, MD	Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for argenx. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NMD Pharma. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon/ Amgen. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyverna. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jansen/Johnson & Johnson. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMDSerono/Merck. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH/NINDS. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunis Biomedical. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman-La Roche. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Habib has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for argenx. Dr. Habib has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Habib has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jansen/Joohnson & Johnson. The institution of Dr. Habib has received research support from Alexion. The institution of Dr. Habib has received research support from Horizon/Amgen. The institution of Dr. Habib has received research support from Immunovant. The institution of Dr. Habib has received research support from UCB. The institution of Dr. Habib has received research support from argenx. The institution of Dr. Habib has received research support from CabalettaBio. The institution of Dr. Habib has received research support from Regeneron. The institution of Dr. Habib has received research support from Arcellx. The institution of Dr. Habib has received research support from Novartis. The institution of Dr. Habib has received research support from EMDSerono/Merck. The institution of Dr. Habib has received research support from Cour Pharmaceuticals.
Lawrence A. Zeidman, MD, FAAN	Dr. Zeidman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson. Dr. Zeidman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Zeidman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Zeidman has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Smith Blake Hill LLC. The institution of Dr. Zeidman has received research support from Octapharma. Dr. Zeidman has received publishing royalties from a publication relating to health care.
P. James B. Dyck, MD, FAAN	Dr. Dyck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea/Ionis.
Michael Althaus	Michael Althaus has received personal compensation for serving as an employee of Merz Pharmaceuticals.
Naim I. Haddad, MD, FAAN	Dr. Haddad has nothing to disclose.
Elizabeth Thiele, MD	Dr. Thiele has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GW Pharma/Jazz. Dr. Thiele has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for zogenix/UCB. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for nobelpharma. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for livanova. Dr. Thiele has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Noema Pharma. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for pyros pharmaceutical/upsher smith. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus Pharmaceuticals. The institution of Dr. Thiele has received research support from GW Pharma/Jazz. The institution of Dr. Thiele has received research support from Zogenix/UCB. The institution of Dr. Thiele has received research support from Stoke Therapeutics. The institution of Dr. Thiele has received research support from Biocodex. Dr. Thiele has received publishing royalties from a publication relating to health care.
Ariyaporn Haripottawekul	Miss Haripottawekul has nothing to disclose.
Dagoberto Callegaro, Sr., PhD	Dr. Callegaro has nothing to disclose.
Huda Alalami, MD	Dr. Alalami has nothing to disclose.
Ramon R. Diaz-Arrastia, MD, PhD, FAAN	Dr. Diaz-Arrastia has stock in BrainBox, LLC. Dr. Diaz-Arrastia has stock in Nia Therpeutics. The institution of Dr. Diaz-Arrastia has received research support from National Institutes of Health. The institution of Dr. Diaz-Arrastia has received research support from Department of Defense.
Kevin Spiegler, MD, PhD	Dr. Spiegler has nothing to disclose.
Sarah L. Wyckoff, BS	Ms. Wyckoff has nothing to disclose.
Carlos A. Perez, MD	Dr. Perez has received personal compensation for serving as an employee of Sanofi-Genzyme.
Meredith F. Yang	Ms. Yang has nothing to disclose.
Sadia Waheed, MBBS	Dr. Waheed has nothing to disclose.
Rebecca Traub, MD, FAAN	Dr. Traub has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Traub has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Traub has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Intellia. The institution of Dr. Traub has received research support from Alnylam Pharmaceuticals. The institution of Dr. Traub has received research support from Muscular Dystrophy Association (MDA). The institution of Dr. Traub has received research support from Ionis. The institution of Dr. Traub has received research support from Argenx. The institution of Dr. Traub has received research support from Pharnext. The institution of Dr. Traub has received research support from Immunovant. The institution of Dr. Traub has received research support from Takeda. Dr. Traub has received personal compensation in the range of $500-$4,999 for serving as a consultant with Department of Justice.
Sarada Sakamuri, MD, FAAN	Dr. Sakamuri has received personal compensation in the range of $0-$499 for serving as a Conference Faculty with AANEM. Dr. Sakamuri has received personal compensation in the range of $0-$499 for serving as a Conference Faculty with ISNMI Neuromuscular Ultrasound Workshop. Dr. Sakamuri has received personal compensation in the range of $0-$499 for serving as a Conference Faculty with Wake Forest University. Dr. Sakamuri has received personal compensation in the range of $0-$499 for serving as a Conference Faculty with Wake Forest University.
Hanah A. Imam, MBBS	Dr. Imam has nothing to disclose.
Yasaman Pirahanchi, MD	Dr. Pirahanchi has nothing to disclose.
Ronak U. Trivedi	Mr. Trivedi has nothing to disclose.
Chandra Sekhar Mannyam, MBBS	Dr. Mannyam has nothing to disclose.
Hussam A. Yacoub, DO	Dr. Yacoub has nothing to disclose.
Biman K. Ray, MD	Dr. Ray has nothing to disclose.
Gary R. Cutter, PhD	Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for onsulting or Advisory Boards: Alexion, Antisense Therapeutics/Percheron, Avotres, Biogen, Clene Nanomedicine, Clinical Trial Solutions LLC, Endra Life Sciences, Cognito Therapeutics, Genzyme, Genentech, Immunic, Klein-Buendel Incorporated, Kyverna Therapeutics, Inc. , Linical, Merck/Serono, Noema, Neurogenesis, Perception Neurosciences, Protalix Biotherapeutics, Regeneron, Revelstone Consulting, Roche, SAB Biotherapeutics, Sapience Therapeutics, Scott&Scott LLP, Tenmile.. Dr. Cutter has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Data and Safety Monitoring Boards: Applied Therapeutics, AI therapeutics, AMO Pharma, Argenx, Astra-Zeneca, Avexis Pharmaceuticals, Bristol Meyers Squibb, CSL Behring, Cynata Therapeutics, DiamedicaTherapeutics, Horizon Pharmaceuticals, Immunic, Inhibrix, Karuna Therapeutics, Kezar Life Sciences, Medtronic, Merck, Meiji Seika Pharma, Mitsubishi Tanabe Pharma Holdings, Prothena Biosciences, Novartis, Pipeline Therapeutics (Contineum), Regeneron, Sanofi-Aventis, Teva Pharmaceuticals, United BioSource LLC, University of Texas Southwestern.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN.
Ayush Agarwal, DM	Dr. Agarwal has nothing to disclose.
Grace L. Liang, MD	Dr. Liang has received personal compensation for serving as an employee of Neurocrine Biosciences. Dr. Liang has stock in Neurocrine Biosciences.
Michael R. Sperling, MD, FAAN	Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. The institution of Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medscape. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for International Medical Press. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Projects for Knowledge. The institution of Dr. Sperling has received research support from SK Life Science. The institution of Dr. Sperling has received research support from UCB Pharma . The institution of Dr. Sperling has received research support from Takeda. The institution of Dr. Sperling has received research support from Neurelis. The institution of Dr. Sperling has received research support from Engage Therapeutics . The institution of Dr. Sperling has received research support from Medtronic. The institution of Dr. Sperling has received research support from Cavion. The institution of Dr. Sperling has received research support from Xenon Pharma. The institution of Dr. Sperling has received research support from Cerevel. The institution of Dr. Sperling has received research support from National Institutes of Health . The institution of Dr. Sperling has received research support from DARPA. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Vice President with Epilepsy Consortium .
Marc Gebara	Mr. Gebara has nothing to disclose.
Ellen M. Mowry, MD, FAAN	Dr. Mowry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octave. Dr. Mowry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SetPoint. The institution of Dr. Mowry has received research support from Genentech/Roche. The institution of Dr. Mowry has received research support from Biogen. Dr. Mowry has received publishing royalties from a publication relating to health care.
Michael A. Figueroa, DO	Dr. Figueroa has nothing to disclose.
Yohei Harada, MD	Dr. Harada has nothing to disclose.
Daniel H. Lench, PhD	Dr. Lench has nothing to disclose.
Bianca Weinstock-Guttman, MD	Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
Christian Lachner	Christian Lachner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerView. Christian Lachner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSL Group Services.
Dirk T. Deleu, MD, PhD, FRCP, FAAN	Dr. Deleu has nothing to disclose.
Ivan Roque Sanchez, MD	Dr. Roque Sanchez has nothing to disclose.
Ankita Ghosh, MD	Dr. Ghosh has nothing to disclose.
Ashley Weng, MD	Dr. Weng has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx.
Junaid Ansari, MD	Dr. Ansari has nothing to disclose.
Aayushi Garg, MBBS	Dr. Garg has nothing to disclose.
Asif Doja, MD, FAAN	Dr. Doja has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology ��ɫ�� . Dr. Doja has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for the CMPA. Dr. Doja has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Integra . Dr. Doja has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Connect Care .
Amrita Pandey, MD	Dr. Pandey has nothing to disclose.
Sayyeda Zahra, MD	Dr. Zahra has nothing to disclose.
Joana Moreira	Joana Moreira has received personal compensation for serving as an employee of BIAL.
Maria Martinez-Lage, MD	The institution of Dr. Martinez-Lage has received research support from NIH.
Dawn C. Buse, PhD	Dr. Buse has received personal compensation for serving as an employee of Vector Psychometric Group. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranicsa. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Buse has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Reports. The institution of Dr. Buse has received research support from Amgen. The institution of Dr. Buse has received research support from FDA. The institution of Dr. Buse has received research support from National Headache Foundation.
Daniel Fernandez-Guzman	No disclosure on file
Muhammed Ors	Mr. Ors has nothing to disclose.
Raghav Talreja, MD	Mr. Talreja has nothing to disclose.
Ivan Murrieta-Alvarez, MD	Dr. Murrieta-Alvarez has nothing to disclose.
Aashka Ponda, Other	Dr. Ponda has nothing to disclose.
Shaheen Sombans, MBBS	Dr. Sombans has nothing to disclose.
Jintong Liu	Miss Liu has nothing to disclose.
Denise Li, MD	Dr. Li has nothing to disclose.
Frank Tennigkeit, PhD	Dr. Tennigkeit has received personal compensation for serving as an employee of UCB Biosciences. Dr. Tennigkeit has stock in UCB Biosciences.
Matt Hobbs	Mr. Hobbs has received personal compensation for serving as an employee of Biogen. Mr. Hobbs has stock in Biogen.
Rafael Joao	Mr. Joao has nothing to disclose.
Alison M. Pack, MD, FAAN	An immediate family member of Dr. Pack has received personal compensation for serving as an employee of REGENEXBIO. The institution of Dr. Pack has received research support from National Institutes of Health. Dr. Pack has received publishing royalties from a publication relating to health care.
Eric Jen	Eric Jen has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc.
Sarah R. Durica, MD	An immediate family member of Dr. Durica has received personal compensation in the range of $100,000-$499,999 for serving as a Employee with Federal Aviation Administration.
Ramsha A. Bhutta, MD	Dr. Bhutta has nothing to disclose.
Marco M. Wolmarans, MD	Mr. Wolmarans has nothing to disclose.
Chindo B. Mallum, MD	Dr. Mallum has nothing to disclose.
Denise K. Sebasigari, MD	Dr. Sebasigari has nothing to disclose.
Ashley Bailey, MD	Dr. Bailey has nothing to disclose.
Saba Ilkhani, MD	Miss Ilkhani has nothing to disclose.
Nancy Song, MD	Dr. Song has nothing to disclose.
Nikoloz Karazanashvili, MD	Dr. Karazanashvili has nothing to disclose.
Catherine L. Passariello, PhD	Dr. Passariello has received personal compensation for serving as an employee of Jazz Pharmaceuticals . Dr. Passariello has stock in Jazz Pharmaceuticals . An immediate family member of Dr. Passariello has stock in UCB Pharmaceuticals . Dr. Passariello has received intellectual property interests from a discovery or technology relating to health care.
Murtaza Khan, MD	Dr. Khan has nothing to disclose.
Jessica DuHaime, PharmD	Dr. DuHaime has received personal compensation for serving as an employee of Jazz Pharmaceuticals. Dr. DuHaime has received personal compensation for serving as an employee of Greenwich Biosciences. Dr. DuHaime has stock in Jazz Pharmaceuticals.
Larry "LC" Charleston IV, MD, MSc, FAHS, FANA, FAAN	Dr. Charleston has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Charleston has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal Pharmaceuticals. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma Pharmaceuticals. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LinPharma. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Haleon. Dr. Charleston has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. The institution of Dr. Charleston has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Axsome. Dr. Charleston has or had stock in Mi-Helper Inc..Dr. Charleston has a non-compensated relationship as a Associate Editor with Headache Journal: The Journal of Head and Face Pain that is relevant to AAN interests or activities. Dr. Charleston has a non-compensated relationship as a Board Member with Clinical Neurological Society of America that is relevant to AAN interests or activities. Dr. Charleston has a non-compensated relationship as a Chair, EDI Advisory Committee (Non-voting Board Member) with American Headache Society that is relevant to AAN interests or activities.
Steven Galetta, MD, FAAN	Dr. Galetta has nothing to disclose.

��ɫ����

��ɫ����

��ɫ��

��ɫ��